Parvalbumin interneuron vulnerability and brain disorders
Open accessAbstract
Parvalbumin-expressing interneurons (PV-INs) are highly vulnerable to stressors and have been implicated in many neuro-psychiatric diseases such as schizophrenia, Alzheimer's disease, autism spectrum disorder, and bipolar disorder. We examined the literature about the current knowledge of the physiological properties of PV-INs and gathered results from diverse research areas to provide insight into their vulnerability to stressors. Among the factors that confer heightened vulnerability are the substantial energy requirements, a strong excitatory drive, and a unique developmental trajectory. Understanding these stressors and elaborating on their impact on PV-IN health is a step toward developing therapies to protect these neurons in various disease states and to retain critical brain functions.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 143 cited sources checked · 0 supported · 0 flagged
- Premisecitation
People with schizophrenia have a lower density of excitatory synapses on PV-INs.
“Furthermore, individuals with schizophrenia have a lower density of excitatory synapses on PV-INs [12] and exhibit alterations in gamma oscillations during a working memory task [13].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Chung DW, Fish KN, Lewis DA. Pathological basis for deficient excitatory drive to cortical parvalbumin interneurons in schizophrenia. Am J Psychiatry. 2016;173:1131–9. source
Not checked in the free run.
- Premisenone given
Damage to or malfunction of PV-INs has been proposed to contribute to the pathophysiology of schizophrenia, autism spectrum disorder, bipolar disorder, neurodegenerative diseases, and aging-related cognitive changes.
“Injury to, or dysfunction of, parvalbumin inhibitory interneurons (PV-INs) has been proposed to contribute to the pathophysiology of several important neuro-psychiatric disorders, including schizophrenia, autism spectrum disorder (ASD), bipolar disorder (BPD), various neurodegenerative diseases, and even aging-related cognitive changes.”
Quote in the paperSubstantial claim - Premisecitation
People with schizophrenia show altered gamma oscillations during a working memory task.
“Furthermore, individuals with schizophrenia have a lower density of excitatory synapses on PV-INs [12] and exhibit alterations in gamma oscillations during a working memory task [13].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Barr MS, Farzan F, Tran LC, Chen R, Fitzgerald PB, Daskalakis ZJ. Evidence for excessive frontal evoked gamma oscillatory activity in schizophrenia during working memory. Schizophr Res. 2010;121:146–52. source
Not checked in the free run.
- Premisecitation
Animal models that mimic schizophrenia reproduce the loss of PV-INs in the hippocampus.
“Animal models that mimic schizophrenia replicate the loss of PV-INs in the hippocampus [6,14,15], and show a loss of PV fluorescence per cell in prelimbic regions [16].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [6] Lodge DJ, Behrens MM, Grace AA. A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci. 2009;29:2344–54. source
Not checked in the free run.
- cites [14] Koh MT, Shao Y, Sherwood A, Smith DR. Impaired hippocampal-dependent memory and reduced parvalbumin-positive interneurons in a ketamine mouse model of schizophrenia. Schizophr Res. 2016;171:187–94. source
Not checked in the free run.
- cites [15] Harrington AJ, Raissi A, Rajkovich K, Berto S, Kumar J, Molinaro G, et al. MEF2C regulates cortical inhibitory and excitatory synapses and behaviors relevant to neurodevelopmental disorders. eLife 2016;5:e20059. source
Not checked in the free run.
- Premisecitation
Early intervention during the prepubertal period may prevent PV-IN loss in the MAM rat model of ventral hippocampal PV-IN loss.
“Interestingly, early intervention during the prepubertal period might prevent loss of PV-INs, as shown in the methylazoxymethanol acetate (MAM) rat model of PV-IN loss in the ventral hippocampus [17].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17] Du Y, Grace AA. Loss of parvalbumin in the hippocampus of MAM schizophrenia model rats is attenuated by peripubertal diazepam. Int J Neuropsychopharmacol. 2016;19:pyw060. source
Not checked in the free run.
- Premisecitation
Reduced numbers of PV-INs have been reported in the hippocampus, entorhinal cortex, and subicular areas in schizophrenia.
“Reductions in the number of PV-INs were reported in the hippocampus, entorhinal cortex, and subicular areas [1,[9][10][11].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [1] Konradi C, Yang CK, Zimmerman EI, Lohmann KM, Gresch P, Pantazopoulos H, et al. Hippocampal interneurons are abnormal in schizophrenia. Schizophr Res. 2011;131:165–73. source
Not checked in the free run.
- cites [9] Wang AY, Lohmann KM, Yang CK, Zimmerman EI, Pantazopoulos H, Herring N, et al. Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region. Acta Neuropathol. 2011;122:615–26. source
Not checked in the free run.
- cites [10] Chung DW, Volk DW, Arion D, Zhang Y, Sampson AR, Lewis DA. Dysregulated ErbB4 splicing in schizophrenia: selective effects on parvalbumin expression. Am J Psychiatry. 2016;173:60–8. source
Not checked in the free run.
- Interpretationreasoning
The available findings cannot distinguish whether PV-INs are lost or whether they stop expressing PV.
“While these findings point to a pathology in PV-INs, they cannot differentiate between loss of neurons or loss of PV expression.”
Quote in the paperSubstantial claim - Premisecitation
Animal models of schizophrenia show reduced PV fluorescence per cell in prelimbic regions.
“Animal models that mimic schizophrenia replicate the loss of PV-INs in the hippocampus [6,14,15], and show a loss of PV fluorescence per cell in prelimbic regions [16].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL, et al. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science. 2007;318:1645–7. source
Not checked in the free run.
- Premisecitation
Hippocampal PV-IN numbers are decreased in two mouse models of Alzheimer's disease.
“For example, decreases in the number of PV-INs in the hippocampus were observed in two mouse models of AD [33,34], while an increase in hippocampal PV immunoreactivity was observed in another [35], and no change in the number of hippocampal PV-positive interneurons was observed in yet another model [36].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [33] Mahar I, Albuquerque MS, Mondragon-Rodriguez S, Cavanagh C, Davoli MA, Chabot JG, et al. Phenotypic alterations in hippocampal NPY- and PV-expressing interneurons in a presymptomatic transgenic mouse model of Alzheimer’s disease. Front Aging Neurosci. 2016;8:327.
Not checked in the free run.
- cites [34] Takahashi H, Brasnjevic I, Rutten BP, Van Der Kolk N, Perl DP, Bouras C, et al. Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer’s disease. Brain Struct Funct. 2010;214:145–60. source
Not checked in the free run.
- Premisecitation
No change in hippocampal PV-positive interneuron number was observed in yet another mouse model of Alzheimer's disease.
“For example, decreases in the number of PV-INs in the hippocampus were observed in two mouse models of AD [33,34], while an increase in hippocampal PV immunoreactivity was observed in another [35], and no change in the number of hippocampal PV-positive interneurons was observed in yet another model [36].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] Albuquerque MS, Mahar I, Davoli MA, Chabot JG, Mechawar N, Quirion R, et al. Regional and sub-regional differences in hippocampal GABAergic neuronal vulnerability in the TgCRND8 mouse model of Alzheimer’s disease. Front Aging Neurosci. 2015;7:30. source
Not checked in the free run.
- Premisecitation
Abnormalities in the default mode network have been observed in AD patients.
“Furthermore, abnormalities in the default mode network, which is regulated in part by PV-INs [27], have been observed in AD patients [28][29][30][31][32].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [28] Jones DT, Machulda MM, Vemuri P, McDade EM, Zeng G, Senjem ML, et al. Age-related changes in the default mode network are more advanced in Alzheimer disease. Neurology. 2011;77:1524–31. source
Not checked in the free run.
- cites [29] Zhang HY, Wang SJ, Liu B, Ma ZL, Yang M, Zhang ZJ, et al. Resting brain connectivity: changes during the progress of Alzheimer disease. Radiology. 2010;256:598–606. source
Not checked in the free run.
- cites [30] Zhou J, Greicius MD, Gennatas ED, Growdon ME, Jang JY, Rabinovici GD, et al. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer’s disease. Brain. 2010;133:1352–67. source
Not checked in the free run.
- Premisecitation
Cortical PV-INs are highly interconnected through electrical and chemical synapses.
“PV-INs in the cortex are highly interconnected via electrical and chemical synapses [69].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [69] Galarreta M, Hestrin S. Electrical and chemical synapses among parvalbumin fast-spiking GABAergic interneurons in adult mouse neocortex. Proc Natl Acad Sci USA. 2002;99:12438–43. source
Not checked in the free run.
- Premisecitation
In Alzheimer's disease patients, PV-INs are increased in the piriform cortex.
“In AD patients, however, a decrease in PV-INs was reported in the dentate gyrus, and an increase in PV-INs was reported in the piriform cortex [34,37,38].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [34] Takahashi H, Brasnjevic I, Rutten BP, Van Der Kolk N, Perl DP, Bouras C, et al. Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer’s disease. Brain Struct Funct. 2010;214:145–60. source
Not checked in the free run.
- cites [37] Baig S, Wilcock GK, Love S. Loss of perineuronal net N-acetylgalactosamine in Alzheimer’s disease. Acta Neuropathol. 2005;110:393–401. source
Not checked in the free run.
- cites [38] Saiz-Sanchez D, De la Rosa-Prieto C, Ubeda-Banon I, Martinez-Marcos A. Interneurons, tau and amyloid-beta in the piriform cortex in Alzheimer’s disease. Brain Struct Funct. 2015;220:2011–25. source
Not checked in the free run.
- Premisecitation
PV knockout mice show behavioral phenotypes resembling core autism spectrum disorder behaviors in humans.
“Concurrently, PV knockout mice display behavioral phenotypes that resemble core behavioral phenotypes found in humans with ASD [53].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [53] Wohr M, Orduz D, Gregory P, Moreno H, Khan U, Vorckel KJ, et al. Lack of parvalbumin in mice leads to behavioral deficits relevant to all human autism core symptoms and related neural morphofunctional abnormalities. Transl Psychiatry. 2015;5:e525. source
Not checked in the free run.
- Premisecitation
Mouse models relevant to both schizophrenia and bipolar disorder, including Disc1 and Bdnf models, show abnormal PV-IN function ranging from migration deficits to reduced interneuron number.
“Mouse models relevant for both disorders, including the disrupted in schizophrenia 1 gene (Disc1) [57][58][59][60][61], or brain derived neurotrophic factor (Bdnf) [62], show abnormal PV-IN function ranging from migration deficits to reduction in IN number.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [57] Lee FH, Zai CC, Cordes SP, Roder JC, Wong AH. Abnormal interneuron development in disrupted-in-schizophrenia-1 L100P mutant mice. Mol Brain. 2013;6:20. source
Not checked in the free run.
- cites [62] Jones NC, Hudson M, Foreman J, Rind G, Hill R, Manning EE, et al. Brain-derived neurotrophic factor haploinsufficiency impairs high-frequency cortical oscillations in mice. Eur J Neurosci. 2018;48:2816–25. source
Not checked in the free run.
- Premisecitation
In other mouse models of autism spectrum disorder, reduced PV-INs or decreased PV immunoreactivity has been reported.
“In other mouse models of ASD, a reduction in PV-INs or a decrease in PV immunoreactivity has been reported [20].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Filice F, Vorckel KJ, Sungur AO, Wohr M, Schwaller B. Reduction in parvalbumin expression not loss of the parvalbumin-expressing GABA interneuron subpopulation in genetic parvalbumin and shank mouse models of autism. Mol Brain. 2016;9:10. source
Not checked in the free run.
- Interpretationreasoning
Reports of PV-IN changes in Alzheimer's disease are controversial.
“Reports of changes of PV-INs in AD are not without controversy.”
Quote in the paperNot a substantial claim - Premisecitation
Several mouse models for both autism spectrum disorder and schizophrenia have large effects on PV-IN function.
“The Df (16)A± transgenic mouse and the LgDel(±) mouse, both of which model the 22q11.2deletion in humans [5,[40][41][42][43], the contactin associated protein 2 mouse [44][45][46], the neurexin transgene model [47], Shank models [20,[48][49][50], and platelet-derived growth factor receptor-beta (Pdgfrb) knockout mouse [51,52] are examples of models for both ASD and schizophrenia, which have large”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [5] Mukherjee A, Carvalho F, Eliez S, Caroni P. Long-lasting rescue of network and cognitive dysfunction in a genetic schizophrenia model. Cell. 2019;178:1387–402 e14. source
Not checked in the free run.
- cites [40] Hamm JP, Peterka DS, Gogos JA, Yuste R. Altered cortical ensembles in mouse models of schizophrenia. Neuron. 2017;94:153–67 e8. source
Not checked in the free run.
- cites [41] Piskorowski RA, Nasrallah K, Diamantopoulou A, Mukai J, Hassan SI, Siegelbaum SA, et al. Age-dependent specific changes in area CA2 of the hippocampus and social memory deficit in a mouse model of the 22q11.2 deletion syndrome. Neuron. 2016;89:163–76. source
Not checked in the free run.
- Premisereasoning
The characteristic phenotype of PV-INs is fast-spiking action potentials at high energetic cost.
“For this reason, the characteristic phenotype of PV-INs is fast-spiking action potentials at high energetic costs [66].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [66] Hu H, Gan J, Jonas P. Interneurons. Fast-spiking, parvalbumin(+) GABAergic interneurons: from cellular design to microcircuit function. Science. 2014;345:1255263. source
Not checked in the free run.
- Interpretationreasoning
The contradictory Alzheimer's disease mouse-model observations may be explained by the different mouse models used.
“These contradicting observations may be explained by the different mouse models used in each study.”
Quote in the paperNot a substantial claim - Premisecitation
The default mode network is regulated in part by PV-INs.
“Furthermore, abnormalities in the default mode network, which is regulated in part by PV-INs [27], have been observed in AD patients [28][29][30][31][32].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] Nair J, Klaassen AL, Arato J, Vyssotski AL, Harvey M, Rainer G. Basal forebrain contributes to default mode network regulation. Proc Natl Acad Sci USA. 2018;115:1352–7. source
Not checked in the free run.
- Premisecitation
PV-INs help create and maintain gamma oscillations, which are high-frequency waves between 20 and 100 Hz.
“They help to create and maintain gamma oscillations, which are high-frequency waves between 20 and 100 Hz [66,75].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [66] Hu H, Gan J, Jonas P. Interneurons. Fast-spiking, parvalbumin(+) GABAergic interneurons: from cellular design to microcircuit function. Science. 2014;345:1255263. source
Not checked in the free run.
- cites [75] Buzsaki G, Wang XJ. Mechanisms of gamma oscillations. Annu Rev Neurosci. 2012;35:203–25. source
Not checked in the free run.
- Premisecitation
Amyloid plaques were reduced when hippocampal PV-INs were made to produce gamma oscillations optogenetically.
“Interestingly, amyloid plaques were reduced when hippocampal PV-INs artificially produced gamma oscillations in optogenetics paradigms [21].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] Iaccarino HF, Singer AC, Martorell AJ, Rudenko A, Gao F, Gillingham TZ, et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature. 2016;540:230–5. source
Not checked in the free run.
- Premisecitation
Alzheimer's disease is associated with changes in fast-spiking interneurons.
“Alzheimer's disease (AD) is also associated with changes in fastspiking interneurons (Table 2).”
Quote in the paperSubstantial claim - Premisecitation
In Alzheimer's disease patients, PV-INs are decreased in the dentate gyrus.
“In AD patients, however, a decrease in PV-INs was reported in the dentate gyrus, and an increase in PV-INs was reported in the piriform cortex [34,37,38].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [34] Takahashi H, Brasnjevic I, Rutten BP, Van Der Kolk N, Perl DP, Bouras C, et al. Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer’s disease. Brain Struct Funct. 2010;214:145–60. source
Not checked in the free run.
- cites [37] Baig S, Wilcock GK, Love S. Loss of perineuronal net N-acetylgalactosamine in Alzheimer’s disease. Acta Neuropathol. 2005;110:393–401. source
Not checked in the free run.
- cites [38] Saiz-Sanchez D, De la Rosa-Prieto C, Ubeda-Banon I, Martinez-Marcos A. Interneurons, tau and amyloid-beta in the piriform cortex in Alzheimer’s disease. Brain Struct Funct. 2015;220:2011–25. source
Not checked in the free run.
- Premisecitation
In a tau seeding model with AD-like pathology, theta-gamma phase-amplitude coupling is impaired before neuronal loss or maximum tau pathology.
“Theta-gamma oscillation phaseamplitude cross-frequency coupling was impaired prior to neuronal loss or maximum tau pathology in a tau seeding model with AD-like pathology [23].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] Ahnaou A, Moechars D, Raeymaekers L, Biermans R, Manyakov NV, Bottelbergs A, et al. Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer’s disease pathology. Sci Rep. 2017;7:14189. source
Not checked in the free run.
- Premisecitation
PV-IN networks are associated with plasticity from early life through adulthood.
“These networks are associated with plasticity from early life throughout adulthood [70][71][72][73].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [70] Donato F, Rompani SB, Caroni P. Parvalbumin-expressing basket-cell network plasticity induced by experience regulates adult learning. Nature. 2013;504:272–6. source
Not checked in the free run.
- cites [71] Yazaki-Sugiyama Y, Kang S, Cateau H, Fukai T, Hensch TK. Bidirectional plasticity in fast-spiking GABA circuits by visual experience. Nature. 2009;462:218–21. source
Not checked in the free run.
- cites [72] Kuhlman SJ, Olivas ND, Tring E, Ikrar T, Xu X, Trachtenberg JT. A disinhibitory microcircuit initiates critical-period plasticity in the visual cortex. Nature. 2013;501:543–6. source
Not checked in the free run.
- Premisecitation
Mecp2 knockout, a model of Rett syndrome, shows repetitive behaviors and stereotypies even when the gene is removed selectively from interneurons.
“One of the best described ASD models, knockout of the gene responsible for Rett syndrome, methyl CpG binding protein 2 (Mecp2), shows repetitive behaviors and stereotypies even if the gene is selectively removed from INs only [54].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [54] Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J, et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature. 2010;468:263–9. source
Not checked in the free run.
- Premisecitation
Evoked gamma oscillations to auditory stimuli are disrupted in the tau seeding AD-like model.
“Evoked gamma oscillations to auditory stimuli were also disrupted in this model [23].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] Ahnaou A, Moechars D, Raeymaekers L, Biermans R, Manyakov NV, Bottelbergs A, et al. Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer’s disease pathology. Sci Rep. 2017;7:14189. source
Not checked in the free run.
- Interpretationreasoning
The different Alzheimer's disease findings could be due to the different brain regions examined.
“The different findings reported in each study could be due to the different brain regions examined.”
Quote in the paperNot a substantial claim - Premisecitation
Hippocampal PV immunoreactivity is increased in another mouse model of Alzheimer's disease.
“For example, decreases in the number of PV-INs in the hippocampus were observed in two mouse models of AD [33,34], while an increase in hippocampal PV immunoreactivity was observed in another [35], and no change in the number of hippocampal PV-positive interneurons was observed in yet another model [36].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [35] Verdaguer E, Brox S, Petrov D, Olloquequi J, Romero R, de Lemos ML, et al. Vulnerability of calbindin, calretinin and parvalbumin in a transgenic/knock-in APPswe/PS1dE9 mouse model of Alzheimer disease together with disruption of hippocampal neurogenesis. Exp Gerontol. 2015;69:176–88. source
Not checked in the free run.
- Premisecitation
The large amounts of ATP needed to sustain gamma oscillations are supplied by a high density of mitochondria.
“The large amounts of ATP needed to sustain gamma oscillations are supplied by a high density of mitochondria [81][82][83].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [81] Kann O, Papageorgiou IE, Draguhn A. Highly energized inhibitory interneurons are a central element for information processing in cortical networks. J Cereb Blood Flow Metab. 2014;34:1270–82. source
Not checked in the free run.
- cites [82] Inan M, Zhao M, Manuszak M, Karakaya C, Rajadhyaksha AM, Pickel VM, et al. Energy deficit in parvalbumin neurons leads to circuit dysfunction, impaired sensory gating and social disability. Neurobiol Dis. 2016;93:35–46. source
Not checked in the free run.
- cites [83] Kann O, Huchzermeyer C, Kovacs R, Wirtz S, Schuelke M. Gamma oscillations in the hippocampus require high complex I gene expression and strong functional performance of mitochondria. Brain. 2011;134:345–58. source
Not checked in the free run.
- Interpretationreasoning
Large calcium waves, high mitochondrial density, and dependence on uninterrupted ATP supply create a delicate balance in PV-INs that can rapidly become pathological.
“The combination of large Ca 2+ waves, high mitochondrial density, and dependence on uninterrupted ATP supply creates a delicate balance in PV-INs that can rapidly turn into pathology.”
Quote in the paperSubstantial claim - Premisecitation
PV-INs connect to many principal neurons.
“In addition, PV-INs connect to many principal neurons [74,75,87,88].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [74] Packer AM, Yuste R. Dense, unspecific connectivity of neocortical parvalbumin-positive interneurons: a canonical microcircuit for inhibition? J Neurosci. 2011;31:13260–71. source
Not checked in the free run.
- cites [75] Buzsaki G, Wang XJ. Mechanisms of gamma oscillations. Annu Rev Neurosci. 2012;35:203–25. source
Not checked in the free run.
- cites [87] Kisvarday ZF, Beaulieu C, Eysel UT. Network of GABAergic large basket cells in cat visual cortex (area 18): implication for lateral disinhibition. J Comp Neurol. 1993;327:398–415. source
Not checked in the free run.
- cites [88] Sik A, Penttonen M, Ylinen A, Buzsaki G. Hippocampal CA1 interneurons: an in vivo intracellular labeling study. J Neurosci. 1995;15:6651–65. source
Not checked in the free run.
- Premisecitation
In CA1 of the rat hippocampus, PV-INs have larger dendritic trees and thicker dendrites than calbindin- or calretinin-positive interneurons.
“In CA1 of the rat hippocampus, PV-INs have larger dendritic trees and thicker dendrites than calbindin-or calretinin-positive interneurons [80].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [80] Gulyas AI, Megias M, Emri Z, Freund TF. Total number and ratio of excitatory and inhibitory synapses converging onto single interneurons of different types in the CA1 area of the rat hippocampus. J Neurosci. 1999;19:10082–97. source
Not checked in the free run.
- Premisecitation
The rate of oxygen consumption during hippocampal gamma oscillations can equal the rate during a seizure.
“Studies have shown that the rate of oxygen consumption during hippocampal gamma oscillations can be equivalent to the rate of oxygen spent during a seizure [83,84].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [83] Kann O, Huchzermeyer C, Kovacs R, Wirtz S, Schuelke M. Gamma oscillations in the hippocampus require high complex I gene expression and strong functional performance of mitochondria. Brain. 2011;134:345–58. source
Not checked in the free run.
- cites [84] Huchzermeyer C, Berndt N, Holzhutter HG, Kann O. Oxygen consumption rates during three different neuronal activity states in the hippocampal CA3 network. J Cereb Blood Flow Metab. 2013;33:263–71. source
Not checked in the free run.
- Premisecitation
In the MAM model of schizophrenia, reduced PV-IN expression correlates with reduced coordinated neuronal activity during task performance in rats.
“In the MAM model of schizophrenia, reduced expression of PV-INs has been correlated with a reduction in coordinated neuronal activity during task performance in rats [6].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Lodge DJ, Behrens MM, Grace AA. A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci. 2009;29:2344–54. source
Not checked in the free run.
- Interpretationreasoning
The energy demands of PV-INs also make them highly susceptible to inflammation.
“The energy requirements of PV-INs also make them highly susceptible to inflammation.”
Quote in the paperSubstantial claim - Premisecitation
Zinc is more potent than calcium at disrupting mitochondrial function.
“Zinc is more potent than Ca 2+ in its ability to disrupt mitochondrial function [109].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [109] Kwak S, Weiss JH. Calcium-permeable AMPA channels in neurodegenerative disease and ischemia. Curr Opin Neurobiol. 2006;16:281–7. source
Not checked in the free run.
- Premisecitation
In rodent models of brain disorders, higher oxidative stress consistently correlates with fewer PV-positive cortical interneurons.
“In rodent models that recapitulate aspects of brain disorders, higher oxidative stress consistently correlates with decreased PV-positive cortical interneurons [92,93].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [92] Steullet P, Cabungcal JH, Coyle J, Didriksen M, Gill K, Grace AA, et al. Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia. Mol Psychiatry. 2017. source
Not checked in the free run.
- cites [93] Cabungcal JH, Nicolas D, Kraftsik R, Cuenod M, Do KQ, Hornung JP. Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons: relevance to schizophrenia. Neurobiol Dis. 2006;22:624–37. source
Not checked in the free run.
- Premisecitation
IL-6 likely signals through STAT3.
“IL-6 is likely signaling through STAT3 [96].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [96] Dugan LL, Ali SS, Shekhtman G, Roberts AJ, Lucero J, Quick KL, et al. IL-6 mediated degeneration of forebrain GABAergic interneurons and cognitive impairment in aged mice through activation of neuronal NADPH oxidase. PLoS ONE. 2009;4:e5518. source
Not checked in the free run.
- Premisecitation
Unlike calcium, zinc influx through calcium-permeable AMPA receptors can cause long-lasting superoxide production in mitochondria.
“Unlike Ca 2+ , the influx of zinc through Ca 2+ -permeable AMPA receptors can lead to a longlasting production of superoxide in mitochondria [112].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [112] Sensi SL, Yin HZ, Carriedo SG, Rao SS, Weiss JH. Preferential Zn2+ influx through Ca2+-permeable AMPA/kainate channels triggers prolonged mitochondrial superoxide production. Proc Natl Acad Sci USA. 1999;96:2414–9. source
Not checked in the free run.
- Premisecitation
Calcium-permeable AMPA receptors are a major entry point for zinc.
“Ca 2+ -permeable AMPA receptors are a major entry point of zinc [111-113].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [111] Yin HZ, Sensi SL, Ogoshi F, Weiss JH. Blockade of Ca2+-permeable AMPA/kainate channels decreases oxygen-glucose deprivation-induced Zn2+ accumulation and neuronal loss in hippocampal pyramidal neurons. J Neurosci. 2002;22:1273–9. source
Not checked in the free run.
- cites [112] Sensi SL, Yin HZ, Carriedo SG, Rao SS, Weiss JH. Preferential Zn2+ influx through Ca2+-permeable AMPA/kainate channels triggers prolonged mitochondrial superoxide production. Proc Natl Acad Sci USA. 1999;96:2414–9. source
Not checked in the free run.
- cites [113] Jia Y, Jeng JM, Sensi SL, Weiss JH. Zn2+ currents are mediated by calcium-permeable AMPA/kainate channels in cultured murine hippocampal neurones. J Physiol. 2002;543:35–48. source
Not checked in the free run.
- Interpretationreasoning
The dependence of most PV-INs on NMDA receptor function is another source of vulnerability.
“The dependence of most PV-INs on NMDA receptor function presents another vulnerability.”
Quote in the paperSubstantial claim - Premisecitation
In animal models with no change in oxidative stress, PV-positive interneuron number was unchanged.
“Conversely, in animal models where no change in oxidative stress was observed, PV-positive interneuron number was not changed [92].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [92] Steullet P, Cabungcal JH, Coyle J, Didriksen M, Gill K, Grace AA, et al. Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia. Mol Psychiatry. 2017. source
Not checked in the free run.
- Premisecitation
This PV-IN injury is linked to IL-6-mediated, Nox2-dependent NADPH oxidase activation and superoxide production.
“This injury is connected to IL-6mediated Nox2-dependent NADPH oxidase activation and production of superoxide [16,95].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [16] Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL, et al. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science. 2007;318:1645–7. source
Not checked in the free run.
- cites [95] Behrens MM, Ali SS, Dugan LL. Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J Neurosci. 2008;28:13957–66. source
Not checked in the free run.
- Premisecitation
Most PV-INs in humans and monkeys express NMDA receptors.
“The majority of PV-INs in humans and monkeys express NMDA receptors [118, 119].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [118] Huntley GW, Vickers JC, Morrison JH. Quantitative localization of NMDAR1 receptor subunit immunoreactivity in inferotemporal and prefrontal association cortices of monkey and human. Brain Res. 1997;749:245–62. source
Not checked in the free run.
- cites [119] Huntley GW, Vickers JC, Janssen W, Brose N, Heinemann SF, Morrison JH. Distribution and synaptic localization of immunocytochemically identified NMDA receptor subunit proteins in sensory-motor and visual cortices of monkey and human. J Neurosci. 1994;14:3603–19. source
Not checked in the free run.
- Premisecitation
PARP-1 causes release of apoptosis-inducing factor through a nuclear signal that reaches mitochondria.
“PARP-1 leads to the release of apoptosis-inducing factor (AIF) via a nuclear signal that proliferates to mitochondria [110].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [110] Hong SJ, Dawson TM, Dawson VL. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol Sci. 2004;25:259–64. source
Not checked in the free run.
- Premisecitation
Even slower, sustained calcium influx through calcium-permeable AMPA receptors can be damaging through neuronal nitric oxide synthase activation, nitric oxide generation, and PARP-1 activation.
“Even slower, consistent Ca 2+ influx through Ca 2+ -permeable AMPA receptors can be damaging via activation of neuronal nitric oxide synthase and generation of nitric oxide and resultant activation of Poly(ADP-ribose) polymerase 1 (PARP-1), (Fig. 1b), [109, 110].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [109] Kwak S, Weiss JH. Calcium-permeable AMPA channels in neurodegenerative disease and ischemia. Curr Opin Neurobiol. 2006;16:281–7. source
Not checked in the free run.
- cites [110] Hong SJ, Dawson TM, Dawson VL. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol Sci. 2004;25:259–64. source
Not checked in the free run.
- Premisecitation
At equivalent concentrations, zinc causes a larger increase in cytochrome c and AIF than calcium.
“At equivalent concentrations, zinc induces a larger increase in cytochrome c and AIF than Ca 2+ [115].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [115] Jiang D, Sullivan PG, Sensi SL, Steward O, Weiss JH. Zn(2+) induces permeability transition pore opening and release of pro-apoptotic peptides from neuronal mitochondria. J Biol Chem. 2001;276:47524–9. source
Not checked in the free run.
- Premisecitation
After becoming postmitotic, interneurons migrate tangentially toward cortical areas and then radially into predetermined cortical layers.
“Once postmitotic, cells migrate tangentially toward cortical areas and then radially into predetermined cortical layers (Fig. 2, steps 1a, 1b, and 2), [129, 130].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [129] Hu JS, Vogt D, Sandberg M, Rubenstein JL. Cortical interneuron development: a tale of time and space. Development. 2017;144:3867–78. source
Not checked in the free run.
- cites [130] Lim L, Mi D, Llorca A, Marin O. Development and functional diversification of cortical interneurons. Neuron. 2018;100:294–313. source
Not checked in the free run.
- Interpretationcitation
The high frequency of interneuron pathologies in the hippocampus and adjacent cortical areas, such as in schizophrenia and bipolar disorder, may partly reflect extended developmental vulnerability.
“The preponderance of interneuron pathologies in the hippocampus and adjacent cortical areas, such as the interneuron pathologies observed in schizophrenia and BPD, might be, at least in part, a reflection of this extended developmental vulnerability [1, 9, 122, 140-142].”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [1] Konradi C, Yang CK, Zimmerman EI, Lohmann KM, Gresch P, Pantazopoulos H, et al. Hippocampal interneurons are abnormal in schizophrenia. Schizophr Res. 2011;131:165–73. source
Not checked in the free run.
- cites [9] Wang AY, Lohmann KM, Yang CK, Zimmerman EI, Pantazopoulos H, Herring N, et al. Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region. Acta Neuropathol. 2011;122:615–26. source
Not checked in the free run.
- cites [122] Konradi C, Heckers S. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharm Ther. 2003;97:153–79. source
Not checked in the free run.
- cites [140] Heckers S, Konradi C. GABAergic mechanisms of hippocampal hyperactivity in schizophrenia. Schizophr Res. 2015;167:4–11. source
Not checked in the free run.
- cites [141] Konradi C, Zimmerman EI, Yang CK, Lohmann KM, Gresch P, Pantazopoulos H, et al. Hippocampal interneurons in bipolar disorder. Arch Gen Psychiatry. 2011;68:340–50. source
Not checked in the free run.
- cites [142] Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes FM. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch Gen Psychiatry. 2002;59:521–9. source
Not checked in the free run.
- The authors state this as an assumption: The developmental process by which interneurons migrate and integrate into cortical networks has vulnerabilities.
- Premisecitation
As interneurons reach their final position, they switch to a molecular program for axon pathfinding and synaptic connections with local excitatory neurons and other interneurons.
“As interneurons assume their final position within a specific region and layer of the cortex and hippocampus, they have to switch to a molecular program designed to establish axon pathfinding and synaptic connections with local excitatory neurons born in the subventricular zone, and with other interneurons that had migrated from areas deep inside the developing brain”
Quote in the paperSubstantial claim - Premisecitation
The parvalbumin fate of PV-INs appears to be established at their origin as progenitors leave the cell cycle.
“Their 'parvalbumin' fate seems to be established at their origin, as the progenitors leave the cell cycle [127, 128].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [127] Wonders CP, Anderson SA. The origin and specification of cortical interneurons. Nat Rev Neurosci. 2006;7:687–96. source
Not checked in the free run.
- cites [128] Bandler RC, Mayer C, Fishell G. Cortical interneuron specification: the juncture of genes, time and geometry. Curr Opin Neurobiol. 2017;42:17–24. source
Not checked in the free run.
- Premisereasoning
The expression of responsive receptors on migrating neurons must be timed with the transmission of guidance factors from remote brain tissues.
“Intracellularly, an expression of responsive receptors on the neurons must be timed with the transmission of guidance factors from remote brain tissues.”
Quote in the paperNot a substantial claim - Interpretationreasoning
This vulnerability contributes to the role of PV-INs in numerous brain disorders.
“This vulnerability contributes to their role in numerous brain disorders.”
Quote in the paperSubstantial claim - Interpretationreasoning
The developmental origin and physiological properties of PV-INs make them uniquely susceptible to environmental disturbances.
“Their ontogeny and physiological properties render them uniquely susceptible to environmental disturbances.”
Quote in the paperSubstantial claim
- May combine two claims. 34
- Classified as probably not a substantial claim. 9
May combine two claims.
PremisecitationPV-expressing interneurons are highly vulnerable to stressors and have been linked to several neuropsychiatric diseases, including schizophrenia, Alzheimer's disease, autism spectrum disorder, and bipolar disorder.
“Parvalbumin-expressing interneurons (PV-INs) are highly vulnerable to stressors and have been implicated in many neuropsychiatric diseases such as schizophrenia, Alzheimer's disease, autism spectrum disorder, and bipolar disorder.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [1] Konradi C, Yang CK, Zimmerman EI, Lohmann KM, Gresch P, Pantazopoulos H, et al. Hippocampal interneurons are abnormal in schizophrenia. Schizophr Res. 2011;131:165–73. source
Not checked in the free run.
- cites [2] Lewis DA, Curley AA, Glausier JR, Volk DW. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci. 2012;35:57–67. source
Not checked in the free run.
- cites [3] Marin O. Interneuron dysfunction in psychiatric disorders. Nat Rev Neurosci. 2012;13:107–20. source
Not checked in the free run.
May combine two claims.
Interpretationnone givenThe main factors that make PV-INs especially vulnerable are their large energy demands, strong excitatory input, and distinctive developmental path.
“Among the factors that confer heightened vulnerability are the substantial energy requirements, a strong excitatory drive, and a unique developmental trajectory.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn schizophrenia, PVALB mRNA levels are lower in the hippocampus and in layer 4 of the dorsolateral prefrontal cortex, and DNA hypermethylation may partly account for this.
“In schizophrenia, lower levels of PVALB mRNA, the gene coding for PV, were seen in the hippocampus and layer 4 of the dorsolateral prefrontal cortex, which might be partially explained by DNA hypermethylation [1,8].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [1] Konradi C, Yang CK, Zimmerman EI, Lohmann KM, Gresch P, Pantazopoulos H, et al. Hippocampal interneurons are abnormal in schizophrenia. Schizophr Res. 2011;131:165–73. source
Not checked in the free run.
- cites [8] Fachim HA, Srisawat U, Dalton CF, Reynolds GP. Parvalbumin promoter hypermethylation in postmortem brain in schizophrenia. Epigenomics. 2018;10:519–24. source
Not checked in the free run.
May combine two claims.
PremisecitationMany reports describe PV-IN-related changes in people with schizophrenia, and animal models that reproduce aspects of the disease support this finding.
“Extensive accounts in the literature point to PV-IN-related changes in individuals with schizophrenia [1][2][3][4], a finding that is supported by various animal models that recapitulate aspects of the disease [5][6][7] (Table 1).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [1] Konradi C, Yang CK, Zimmerman EI, Lohmann KM, Gresch P, Pantazopoulos H, et al. Hippocampal interneurons are abnormal in schizophrenia. Schizophr Res. 2011;131:165–73. source
Not checked in the free run.
- cites [2] Lewis DA, Curley AA, Glausier JR, Volk DW. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci. 2012;35:57–67. source
Not checked in the free run.
- cites [3] Marin O. Interneuron dysfunction in psychiatric disorders. Nat Rev Neurosci. 2012;13:107–20. source
Not checked in the free run.
May combine two claims.
PremisecitationSome human and animal data suggest that PV-INs may remain present but cease to express PV, although a definitive conclusion cannot yet be drawn.
“Some human and animal model data suggest that formerly PV-INs are still present but cease to express PV, though a definitive conclusion cannot be drawn at this point [7,[18][19][20].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [7] Gill KM, Grace AA. Corresponding decrease in neuronal markers signals progressive parvalbumin neuron loss in MAM schizophrenia model. Int J Neuropsychopharmacol. 2014;17:1609–19. source
Not checked in the free run.
- cites [18] Powell SB, Sejnowski TJ, Behrens MM. Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia. Neuropharmacology. 2012;62:1322–31. source
Not checked in the free run.
- cites [19] Enwright JF, Sanapala S, Foglio A, Berry R, Fish KN, Lewis DA. Reduced labeling of parvalbumin neurons and perineuronal nets in the dorsolateral prefrontal cortex of subjects with schizophrenia. Neuropsychopharmacology. 2016;41:2206–14. source
Not checked in the free run.
May combine two claims.
PremisecitationStimulating PV-INs increases gamma oscillation patterns, whereas inhibiting PV-INs or downregulating PV at cortical synapses reduces gamma oscillations.
“Stimulation of PV-INs leads to an increase in gamma oscillation patterns, while inhibition of PV-INs or downregulation of PV at cortical synapses reduces gamma oscillations [76][77][78].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [76] Cardin JA, Carlen M, Meletis K, Knoblich U, Zhang F, Deisseroth K, et al. Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature. 2009;459:663–7. source
Not checked in the free run.
- cites [77] Sohal VS, Zhang F, Yizhar O, Deisseroth K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature. 2009;459:698–702. source
Not checked in the free run.
- cites [78] Volman V, Behrens MM, Sejnowski TJ. Downregulation of parvalbumin at cortical GABA synapses reduces network gamma oscillatory activity. J Neurosci. 2011;31:18137–48. source
Not checked in the free run.
May combine two claims.
PremisecitationTransgenic mice with AD-like pathology have reduced gamma power, and in one model this reduction precedes cognitive impairment and amyloid plaque formation.
“Transgenic mice with AD-like pathology were found to have reduced gamma power that, in one model, precedes cognitive impairment and amyloid plaque formation [21,22].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [21] Iaccarino HF, Singer AC, Martorell AJ, Rudenko A, Gao F, Gillingham TZ, et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature. 2016;540:230–5. source
Not checked in the free run.
- cites [22] Rubio SE, Vega-Flores G, Martinez A, Bosch C, Perez-Mediavilla A, del Rio J, et al. Accelerated aging of the GABAergic septohippocampal pathway and decreased hippocampal rhythms in a mouse model of Alzheimer’s disease. FASEB J. 2012;26:4458–67. source
Not checked in the free run.
May combine two claims.
PremisereasoningBecause PV rapidly sequesters calcium, it strongly reduces the calcium-activated potassium conductance responsible for postspike hyperpolarization, which partly explains why PV-INs repolarize and fire faster than other neurons.
“Since PV rapidly sequesters Ca 2+ , it strongly attenuates the Ca 2+ -activated potassium conductance responsible for postspike hyperpolarization, which explains in part why PV-INs repolarize faster and fire faster than other neurons.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIndividual PV-INs contact nearly every local pyramidal neuron, which allows them to synchronize networks.
“Individual PV-INs contact nearly every local pyramidal neuron which enables them to synchronize networks [74].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [74] Packer AM, Yuste R. Dense, unspecific connectivity of neocortical parvalbumin-positive interneurons: a canonical microcircuit for inhibition? J Neurosci. 2011;31:13260–71. source
Not checked in the free run.
May combine two claims.
PremisecitationPV-INs participate in feedforward and feedback inhibition, regulation of sensory responses, and learning and plasticity.
“PV-INs have roles in both feedforward and feedback inhibition, regulation of sensory responses, and in learning and plasticity [66].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [66] Hu H, Gan J, Jonas P. Interneurons. Fast-spiking, parvalbumin(+) GABAergic interneurons: from cellular design to microcircuit function. Science. 2014;345:1255263. source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThere is ample evidence that PV-INs are vital for brain function and closely linked to brain malfunction.
“There is therefore ample evidence that PV-INs are vital for brain function and intricately linked to brain malfunction.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationEpilepsy and prion disease are among other disorders associated with alterations in PV-INs.
“Epilepsy [63,64] and prion disease [65] are among other disorders that are associated with alterations in PV-INs.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [63] Sloviter RS, Sollas AL, Barbaro NM, Laxer KD. Calcium-binding protein (calbindin-D28K) and parvalbumin immunocytochemistry in the normal and epileptic human hippocampus. J Comp Neurol. 1991;308:381–96. source
Not checked in the free run.
- cites [64] Garbelli R, Meroni A, Magnaghi G, Beolchi MS, Ferrario A, Tassi L, et al. Architectural (Type IA) focal cortical dysplasia and parvalbumin immunostaining in temporal lobe epilepsy. Epilepsia. 2006;47:1074–8. source
Not checked in the free run.
- cites [65] Guentchev M, Hainfellner JA, Trabattoni GR, Budka H. Distribution of parvalbumin-immunoreactive neurons in brain correlates with hippocampal and temporal cortical pathology in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol. 1997;56:1119–24. source
Not checked in the free run.
May combine two claims.
PremisecitationSchizophrenia shares significant overlap with bipolar disorder, including PV-IN pathology.
“Schizophrenia also shares significant overlap with BPD [55,56], including PV-IN pathology.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [55] Consortium C-DGotPG, Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45:984–94. source
Not checked in the free run.
- cites [56] Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P. A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry. 2002;159:539–45. source
Not checked in the free run.
May combine two claims.
PremisecitationPV increases the rate of calcium sequestration, lowers presynaptic calcium levels, modulates short-term synaptic plasticity, and prevents cumulative facilitation.
“PV increases the rate of Ca 2+ sequestration, reduces presynaptic Ca 2+ levels, modulates short-term synaptic plasticity, and prevents cumulative facilitation (Fig. 1), [67,68].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [67] Caillard O, Moreno H, Schwaller B, Llano I, Celio MR, Marty A. Role of the calcium-binding protein parvalbumin in short-term synaptic plasticity. Proc Natl Acad Sci USA. 2000;97:13372–7. source
Not checked in the free run.
- cites [68] Wahr PA, Michele DE, Metzger JM. Parvalbumin gene transfer corrects diastolic dysfunction in diseased cardiac myocytes. Proc Natl Acad Sci USA. 1999;96:11982–5. source
Not checked in the free run.
May combine two claims.
PremisecitationNav1.1, a voltage-gated sodium channel found largely on PV-IN axons, is decreased in a mouse model with amyloid pathology and in AD patients.
“Separately, a voltage-gated sodium channel (Na v 1.1) that is largely found on axons of PV-INs was decreased in a mouse model with amyloid pathology, and in AD patients [24][25][26].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [24] Ogiwara I, Miyamoto H, Morita N, Atapour N, Mazaki E, Inoue I, et al. Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J Neurosci. 2007;27:5903–14. source
Not checked in the free run.
- cites [25] Wang W, Takashima S, Segawa Y, Itoh M, Shi X, Hwang SK, et al. The developmental changes of Na(v)1.1 and Na(v)1.2 expression in the human hippocampus and temporal lobe. Brain Res. 2011;1389:61–70. source
Not checked in the free run.
- cites [26] Verret L, Mann EO, Hang GB, Barth AM, Cobos I, Ho K, et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell. 2012;149:708–21. source
Not checked in the free run.
May combine two claims.
PremisecitationAutism spectrum disorder shares clinical overlap with schizophrenia and similar PV-IN abnormalities.
“ASD shares many overlaps with schizophrenia, not just on a clinical scale, but also with similar PV-IN abnormalities [39].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [39] De Crescenzo F, Postorino V, Siracusano M, Riccioni A, Armando M, Curatolo P, et al. Autistic symptoms in schizophrenia spectrum disorders: a systematic review and meta-analysis. Front Psychiatry. 2019;10:78. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn humans, gamma oscillations are associated with increased working memory load.
“Gamma oscillations in humans are also associated with increased working memory load [79].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [79] Howard MW, Rizzuto DS, Caplan JB, Madsen JR, Lisman J, Aschenbrenner-Scheibe R, et al. Gamma oscillations correlate with working memory load in humans. Cereb Cortex. 2003;13:1369–74. source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing). May combine two claims.
InterpretationreasoningIt would be surprising if PV-IN densities in disease were uniform across all brain regions, because fast-spiking interneurons have different functions in different areas.
“Indeed, it would be surprising to find that PV-IN densities in disease are uniform across every brain region given that fast-spiking interneurons have different functions in different brain areas.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationRestoring Nav1.1 levels increased gamma oscillations and reduced memory deficits and premature deaths.
“Restoration of the levels of this voltage-gated sodium channel increased gamma oscillations, while memory deficits and premature deaths decreased [26].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [26] Verret L, Mann EO, Hang GB, Barth AM, Cobos I, Ho K, et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell. 2012;149:708–21. source
Not checked in the free run.
May combine two claims.
PremisecitationPV-INs have extraordinary energy requirements to support high metabolic activity and to protect against significant glutamatergic stress.
“PV-INs have extraordinary energy requirements to support a high metabolic activity and to protect against significant glutamatergic stress [16,80,81].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [16] Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL, et al. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science. 2007;318:1645–7. source
Not checked in the free run.
- cites [80] Gulyas AI, Megias M, Emri Z, Freund TF. Total number and ratio of excitatory and inhibitory synapses converging onto single interneurons of different types in the CA1 area of the rat hippocampus. J Neurosci. 1999;19:10082–97. source
Not checked in the free run.
- cites [81] Kann O, Papageorgiou IE, Draguhn A. Highly energized inhibitory interneurons are a central element for information processing in cortical networks. J Cereb Blood Flow Metab. 2014;34:1270–82. source
Not checked in the free run.
May combine two claims.
PremisecitationA substantial amount of cytochrome c and cytochrome c oxidase supports the high bioenergetic needs of PV-INs, but cytochrome c is also central to apoptosis induction.
“A substantial quantity of cytochrome c and cytochrome c oxidase supports the high bioenergetic needs of PV-INs [81,85], but comes at a price as cytochrome c is also central to the induction of apoptosis [86].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [81] Kann O, Papageorgiou IE, Draguhn A. Highly energized inhibitory interneurons are a central element for information processing in cortical networks. J Cereb Blood Flow Metab. 2014;34:1270–82. source
Not checked in the free run.
- cites [85] Gulyas AI, Buzsaki G, Freund TF, Hirase H. Populations of hippocampal inhibitory neurons express different levels of cytochrome c. Eur J Neurosci. 2006;23:2581–94. source
Not checked in the free run.
- cites [86] Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 1996;86:147–57. source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe energy demands of PV-INs make them highly susceptible to loss of mitochondrial membrane potential and to metabolic and oxidative stress that accompanies disease states.
“The energy requirements of PV-INs make them highly susceptible to the loss of mitochondrial membrane potential (a component of, and a proxy for, a decrease in mitochondrial function), and to metabolic and oxidative stress that accompanies disease states [81,91].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [81] Kann O, Papageorgiou IE, Draguhn A. Highly energized inhibitory interneurons are a central element for information processing in cortical networks. J Cereb Blood Flow Metab. 2014;34:1270–82. source
Not checked in the free run.
- cites [91] Whittaker RG, Turnbull DM, Whittington MA, Cunningham MO. Impaired mitochondrial function abolishes gamma oscillations in the hippocampus through an effect on fast-spiking interneurons. Brain. 2011;134:e180. author reply e81 source
Not checked in the free run.
May combine two claims.
PremisecitationIf the pathological threshold is crossed, the electron transfer chain is disrupted, reactive oxygen species accumulate, the permeability transition pore opens, the outer mitochondrial membrane ruptures, cytochrome c is released, and an apoptotic program is activated.
“If the pathological threshold is crossed, the electron transfer chain is disrupted, reactive oxygen species accumulate, the permeability transition pore opens, the outer mitochondrial membrane ruptures, cytochrome c is released, and an apoptotic cell death program is activated [86,109].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [86] Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 1996;86:147–57. source
Not checked in the free run.
- cites [109] Kwak S, Weiss JH. Calcium-permeable AMPA channels in neurodegenerative disease and ischemia. Curr Opin Neurobiol. 2006;16:281–7. source
Not checked in the free run.
May combine two claims.
PremisecitationPV-INs have a higher density of inputs, more excitatory and inhibitory synapses, and a higher ratio of inhibitory to excitatory inputs than calbindin- and calretinin-positive interneurons.
“PV-INs have a higher density of inputs, more excitatory and inhibitory synapses, and a higher ratio of inhibitory to excitatory inputs than calbindin-and calretinin-positive interneurons [80].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [80] Gulyas AI, Megias M, Emri Z, Freund TF. Total number and ratio of excitatory and inhibitory synapses converging onto single interneurons of different types in the CA1 area of the rat hippocampus. J Neurosci. 1999;19:10082–97. source
Not checked in the free run.
May combine two claims.
PremisecitationBlocking calcium-permeable AMPA receptors reduces cortical neuron death in an in vitro traumatic brain injury model, hippocampal pyramidal neuron loss in an oxygen-glucose deprivation slice model, and retinal ganglion cell loss in a glaucoma rat model.
“Consistent with the notion that the presence of Ca 2+ -permeable AMPA receptors contributes to the vulnerability of PV-INs, blocking of these receptors attenuates cortical neuron death in an in vitro model of traumatic brain injury; attenuates hippocampal pyramidal neuron loss in a mouse hippocampal slice model of oxygen-glucose deprivation; and attenuates retinal ganglion cells loss in a rat”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [111] Yin HZ, Sensi SL, Ogoshi F, Weiss JH. Blockade of Ca2+-permeable AMPA/kainate channels decreases oxygen-glucose deprivation-induced Zn2+ accumulation and neuronal loss in hippocampal pyramidal neurons. J Neurosci. 2002;22:1273–9. source
Not checked in the free run.
- cites [116] Cueva Vargas JL, Osswald IK, Unsain N, Aurousseau MR, Barker PA, Bowie D, et al. Soluble tumor necrosis factor alpha promotes retinal ganglion cell death in glaucoma via calcium-permeable AMPA receptor activation. J Neurosci. 2015;35:12088–102. source
Not checked in the free run.
- cites [117] Spaethling JM, Klein DM, Singh P, Meaney DF. Calcium-permeable AMPA receptors appear in cortical neurons after traumatic mechanical injury and contribute to neuronal fate. J Neurotrauma. 2008;25:1207–16. source
Not checked in the free run.
May combine two claims.
PremisecitationIn the hippocampus, oxidative stress is associated with fewer PV-INs and reduced gamma oscillations.
“In the hippocampus, oxidative stress was associated with a decrease in PV-INs as well as a reduction in gamma oscillations [94].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [94] Steullet P, Cabungcal JH, Kulak A, Kraftsik R, Chen Y, Dalton TP, et al. Redox dysregulation affects the ventral but not dorsal hippocampus: impairment of parvalbumin neurons, gamma oscillations, and related behaviors. J Neurosci. 2010;30:2547–58. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenAnimal studies suggest that a key mechanism of neural oscillations involves glutamatergic regulation.
“Animal studies suggest that a key mechanism of neural oscillations is through glutamatergic regulation.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationNMDA receptors in PV-INs regulate gamma rhythms and cognitive behaviors.
“Importantly, NMDA receptors in PV-INs are regulating gamma rhythms and cognitive behaviors [121].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [121] Carlen M, Meletis K, Siegle JH, Cardin JA, Futai K, Vierling-Claassen D, et al. A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Mol Psychiatry. 2012;17:537–48. source
Not checked in the free run.
May combine two claims.
PremisecitationPV-INs receive the greatest excitatory input of any inhibitory neuron population in the cortex, placing them under intense stress.
“Indeed, PV-INs receive the greatest excitatory input of any population of inhibitory neurons in the cortex, which puts them under intense stress [16,80].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [16] Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL, et al. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science. 2007;318:1645–7. source
Not checked in the free run.
- cites [80] Gulyas AI, Megias M, Emri Z, Freund TF. Total number and ratio of excitatory and inhibitory synapses converging onto single interneurons of different types in the CA1 area of the rat hippocampus. J Neurosci. 1999;19:10082–97. source
Not checked in the free run.
May combine two claims.
PremisecitationSTAT3 can directly regulate mitochondrial function, and Nox2 can modulate mitochondrial activity.
“STAT3 can directly regulate mitochondrial function [97,98], and Nox2 can modulate mitochondrial activity [99][100][101]”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [97] Gough DJ, Corlett A, Schlessinger K, Wegrzyn J, Larner AC, Levy DE. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science. 2009;324:1713–6. source
Not checked in the free run.
- cites [98] Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T, et al. Function of mitochondrial Stat3 in cellular respiration. Science. 2009;323:793–7. source
Not checked in the free run.
- cites [99] Kim YM, Kim SJ, Tatsunami R, Yamamura H, Fukai T, Ushio-Fukai M. ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis. Am J Physiol Cell Physiol. 2017;312:C749–64. source
Not checked in the free run.
- cites [100] Joseph LC, Barca E, Subramanyam P, Komrowski M, Pajvani U, Colecraft HM, et al. Inhibition of NAPDH oxidase 2 (NOX2) prevents oxidative stress and mitochondrial abnormalities caused by saturated fat in cardiomyocytes. PLoS ONE. 2016;11:e0145750. source
Not checked in the free run.
May combine two claims.
PremisecitationKetamine, a pro-inflammatory stimulus, injures PV-INs in vitro and in vivo.
“For example, the NMDA receptor antagonist ketamine, a pro-inflammatory stimulus, injures PV-INs in vitro and in vivo [16,95].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [16] Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL, et al. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science. 2007;318:1645–7. source
Not checked in the free run.
- cites [95] Behrens MM, Ali SS, Dugan LL. Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J Neurosci. 2008;28:13957–66. source
Not checked in the free run.
May combine two claims.
PremisecitationZinc influx into neurons leads to nitric oxide generation, PARP-1 activation, and cell death.
“Like Ca 2+ influx, zinc influx into neurons leads to the generation of nitric oxide and subsequent activation of PARP-1 and cell death [114].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [114] Kim YH, Koh JY. The role of NADPH oxidase and neuronal nitric oxide synthase in zinc-induced poly(ADP-ribose) polymerase activation and cell death in cortical culture. Exp Neurol. 2002;177:407–18. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThese receptors activate intraneuronal signaling cascades that remodel microtubule and actin cytoskeletal components to extend and retract processes that move cells toward their destination.
“These receptors activate intraneuronal signaling cascades that dynamically remodel microtubule and actin cytoskeletal components to extend and retract processes that move the cells toward their destination [133].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [133] Peyre E, Silva CG, Nguyen L. Crosstalk between intracellular and extracellular signals regulating interneuron production, migration and integration into the cortex. Front Cell Neurosci. 2015;9:129. source
Not checked in the free run.
May combine two claims.
PremisecitationIn schizophrenia, NMDA receptors are believed to be hypo-functioning, and NMDA receptor inhibition reproduces many schizophrenia symptoms.
“In schizophrenia, NMDA receptors are believed to be hypo-functioning, and the inhibition of NMDA receptors recapitulates many of the symptoms of schizophrenia [104, 122, 123].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [104] Timofeeva OA, Levin ED. Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia. Neuroscience. 2011;195:21–36. source
Not checked in the free run.
- cites [122] Konradi C, Heckers S. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharm Ther. 2003;97:153–79. source
Not checked in the free run.
- cites [123] Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S, et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 2008;31:234–42. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenWorking memory is notably impaired in schizophrenia and other neuropsychiatric diseases, likely because disinhibition changes gamma oscillation power.
“Working memory is notably impaired in schizophrenia and in other neuro-psychiatric diseases likely due to the expected change in gamma oscillation power resulting from disinhibition”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenPV-INs, like other interneurons, arise from progenitor cells in the embryonic ganglionic eminences of the ventral telencephalon.
“Like other interneurons, PV-INs are derived from progenitor cells in the embryonic ganglionic eminences of the ventral telencephalon of the developing brain (Fig. 2).”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningPV-INs are implicated in neurodevelopmental diseases such as early-onset psychiatric disorders and in neurodegenerative diseases such as Alzheimer's disease, showing vulnerability throughout life.
“PV-INs are implicated in neurodevelopmental diseases such as early-onset psychiatric disorders and in neurodegenerative diseases such as AD, demonstrating the vulnerability of this interneuron subset throughout life.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAttractant and repellant guidance factors from various brain regions guide migrating neurons to their destination.
“Externally, an exquisite coordination of attractant and repellant guidance factors transmitted from various brain regions guide migrating neurons to their ultimate destination [132].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [132] Marin O, Valiente M, Ge X, Tsai LH. Guiding neuronal cell migrations. Cold Spring Harb Perspect Biol. 2010;2:a001834. source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenPV-INs are important for proper brain function.
“PV-INs are important for proper brain function.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDuring migration, cell-intrinsic programs and external cues must be coordinated in a time- and location-sensitive way.
“During migration, cellintrinsic programs and external cues must be coordinated in a time-and location-sensitive manner [131].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [131] Guo J, Anton ES. Decision making during interneuron migration in the developing cerebral cortex. Trends Cell Biol. 2014;24:342–51. source
Not checked in the free run.
May combine two claims.
PremisecitationNMDA receptor antagonists such as ketamine and phencyclidine can transiently reproduce key clinical features of schizophrenia and are believed to reduce PV-IN excitation.
“NMDA receptor antagonists, such as ketamine and phencyclidine, can transiently reproduce key clinical features of schizophrenia, and are believed to reduce PV-IN excitation [123].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [123] Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S, et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 2008;31:234–42. source
Not checked in the free run.
The authors state this as an assumption.
The developmental process by which interneurons migrate and integrate into cortical networks has vulnerabilities.
“While there likely is some space to correct for minor variabilities, it seems reasonable to assume that the process also has some vulnerabilities.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Dysfunction and/or deficient inhibitory output from PV interneurons may be a common mechanism of multiple psychiatric disorders, such as schizophrenia, autism spectrum disorders and bipolar disorder.
“Dysfunction and/or deficient inhibitory output from PV interneurons may be a common mechanism of multiple psychiatric disorders, such as schizophrenia (SCZ) (Lewis et al. 2005), autism spectrum disorders (ASD) (Gao and Penzes 2015) and bipolar disorder (BD) (Ruden et al. 2021).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Ruden et al. 2021
Cites
1 retracted
Chen, L. Y., Jiang, M., Zhang, B., Gökçe, Ö., & Südhof, T. C. (2017) · Neuron · doi:10.1016/j.neuron.2017.04.011 · Cited by 207 · see citing works
RetractedShrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,949 · see citing works
Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
Liu, X., Kim, C. N., Yang, J., Jemmerson, R., & Wang, X. (1996) · Cell · doi:10.1016/s0092-8674(00)80085-9 · Cited by 5,167 · see citing works
Greicius, M. D., Srivastava, G., Reiss, A. L., & Menon, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308627101 · Cited by 3,684 · see citing works
Mechanisms of Gamma Oscillations
Buzsáki, G., & Wang, X.-J. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150444 · Cited by 2,796 · see citing works
Parvalbumin neurons and gamma rhythms enhance cortical circuit performance
Sohal, V. S., Zhang, F., Yizhar, O., & Deisseroth, K. (2009) · Nature · doi:10.1038/nature07991 · Cited by 2,606 · see citing works
Driving fast-spiking cells induces gamma rhythm and controls sensory responses
Cardin, J. A., Carlén, M., Meletis, K., Knoblich, U., Zhang, F., Deisseroth, K., Tsai, L.-H., & Moore, C. I. (2009) · Nature · doi:10.1038/nature08002 · Cited by 2,603 · see citing works
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
Cross-Disorder Group of the Psychiatric Genomics Consortium (2013) · Nature Genetics · doi:10.1038/ng.2711 · Cited by 2,263 · see citing works
GABAergic Interneurons in the Neocortex: From Cellular Properties to Circuits
Tremblay, R., Lee, S., & Rudy, B. (2016) · Neuron · doi:10.1016/j.neuron.2016.06.033 · Cited by 2,033 · see citing works
Gamma frequency entrainment attenuates amyloid load and modifies microglia
Iaccarino, H. F., Singer, A. C., Martorell, A. J., Rudenko, A., Gao, F., Gillingham, T. Z., Mathys, H., Seo, J., Kritskiy, O., Abdurrob, F., et al. (2016) · Nature · doi:10.1038/nature20587 · Cited by 1,328 · see citing works
Verret, L., Mann, E. O., Hang, G. B., Barth, A. M. I., Cobos, I., Ho, K., Devidze, N., Masliah, E., Kreitzer, A. C., Mody, I., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.046 · Cited by 1,216 · see citing works
Hu, H., Gan, J., & Jonas, P. (2014) · Science · doi:10.1126/science.1255263 · Cited by 1,197 · see citing works
Interneuron dysfunction in psychiatric disorders
Marín, O. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3155 · Cited by 1,190 · see citing works
Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes
Chao, H.-T., Chen, H., Samaco, R. C., Xue, M., Chahrour, M., Yoo, J., Neul, J. L., Gong, S., Lu, H.-C., Heintz, N., et al. (2010) · Nature · doi:10.1038/nature09582 · Cited by 1,168 · see citing works
Peñagarikano, O., Abrahams, B. S., Herman, E. I., Winden, K. D., Gdalyahu, A., Dong, H., Sonnenblick, L. I., Gruver, R., Almajano, J., Bragin, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.040 · Cited by 1,075 · see citing works
Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia
Lewis, D. A., Curley, A. A., Glausier, J. R., & Volk, D. W. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.10.004 · Cited by 1,071 · see citing works
High rates of schizophrenia in adults with velo-cardio-facial syndrome
Murphy, K. C., Jones, L. A., & Owen, M. J. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.10.940 · Cited by 1,024 · see citing works
Zhou, J., Greicius, M. D., Gennatas, E. D., Growdon, M. E., Jang, J. Y., Rabinovici, G. D., Kramer, J. H., Weiner, M., Miller, B. L., & Seeley, W. W. (2010) · Brain · doi:10.1093/brain/awq075 · Cited by 1,016 · see citing works
Function of Mitochondrial Stat3 in Cellular Respiration
Wegrzyn, J., Potla, R., Chwae, Y.-J., Sepuri, N. B. V., Zhang, Q., Koeck, T., Derecka, M., Szczepanek, K., Szelag, M., Gornicka, A., et al. (2009) · Science · doi:10.1126/science.1164551 · Cited by 1,014 · see citing works
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010 · see citing works
The origin and specification of cortical interneurons
Wonders, C. P., & Anderson, S. A. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1954 · Cited by 980 · see citing works
Ogiwara, I., Miyamoto, H., Morita, N., Atapour, N., Mazaki, E., Inoue, I., Takeuchi, T., Itohara, S., Yanagawa, Y., Obata, K., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5270-06.2007 · Cited by 879 · see citing works
Gamma Oscillations Correlate with Working Memory Load in Humans
Howard, M. W. (2003) · Cerebral Cortex · doi:10.1093/cercor/bhg084 · Cited by 766 · see citing works
Buhl, E. H., Halasy, K., & Somogyi, P. (1994) · Nature · doi:10.1038/368823a0 · Cited by 728 · see citing works
Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation
Gough, D. J., Corlett, A., Schlessinger, K., Wegrzyn, J., Larner, A. C., & Levy, D. E. (2009) · Science · doi:10.1126/science.1171721 · Cited by 716 · see citing works
Development and Functional Diversification of Cortical Interneurons
Lim, L., Mi, D., Llorca, A., & Marín, O. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.009 · Cited by 714 · see citing works
Parvalbumin-expressing basket-cell network plasticity induced by experience regulates adult learning
Donato, F., Rompani, S. B., & Caroni, P. (2013) · Nature · doi:10.1038/nature12866 · Cited by 703 · see citing works
Akbarian, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820150007001 · Cited by 679 · see citing works
Hippocampal CA1 interneurons: an in vivo intracellular labeling study
Sik, A., Penttonen, M., Ylinen, A., & Buzsaki, G. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06651.1995 · Cited by 669 · see citing works
Carlén, M., Meletis, K., Siegle, J. H., Cardin, J. A., Futai, K., Vierling-Claassen, D., Rühlmann, C., Jones, S. R., Deisseroth, K., Sheng, M., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.31 · Cited by 669 · see citing works
Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model
Stark, K. L., Xu, B., Bagchi, A., Lai, W.-S., Liu, H., Hsu, R., Wan, X., Pavlidis, P., Mills, A. A., Karayiorgou, M., et al. (2008) · Nature Genetics · doi:10.1038/ng.138 · Cited by 648 · see citing works
Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase
Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L. (2007) · Science · doi:10.1126/science.1148045 · Cited by 585 · see citing works
Self-citationMutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation
Berkel, S., Marshall, C. R., Weiss, B., Howe, J., Roeth, R., Moog, U., Endris, V., Roberts, W., Szatmari, P., Pinto, D., et al. (2010) · Nature Genetics · doi:10.1038/ng.589 · Cited by 563 · see citing works
Fuchs, E. C., Zivkovic, A. R., Cunningham, M. O., Middleton, S., LeBeau, F. E. N., Bannerman, D. M., Rozov, A., Whittington, M. A., Traub, R. D., Rawlins, J. N. P., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.031 · Cited by 532 · see citing works
Behavioral phenotypes of Disc1 missense mutations in mice
Clapcote, S. J., Lipina, T. V., Millar, J. K., Mackie, S., Christie, S., Ogawa, F., Lerch, J. P., Trimble, K., Uchiyama, M., Sakuraba, Y., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.04.015 · Cited by 526 · see citing works
Packer, A. M., & Yuste, R. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3131-11.2011 · Cited by 506 · see citing works
Alterations in Cortical Network Oscillations and Parvalbumin Neurons in Schizophrenia
Gonzalez-Burgos, G., Cho, R. Y., & Lewis, D. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.03.010 · Cited by 497 · see citing works
Lodge, D. J., Behrens, M. M., & Grace, A. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5419-08.2009 · Cited by 488 · see citing works
Gulyás, A. I., Megı́as, M., Emri, Z., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-22-10082.1999 · Cited by 476 · see citing works
SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients
Shcheglovitov, A., Shcheglovitova, O., Yazawa, M., Portmann, T., Shu, R., Sebastiano, V., Krawisz, A., Froehlich, W., Bernstein, J. A., Hallmayer, J. F., et al. (2013) · Nature · doi:10.1038/nature12618 · Cited by 470 · see citing works
Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling
Hong, S. J., Dawson, T. M., & Dawson, V. L. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.03.005 · Cited by 463 · see citing works
A Twin Study of Genetic Relationships Between Psychotic Symptoms
Cardno, A. G., Rijsdijk, F. V., Sham, P. C., Murray, R. M., & McGuffin, P. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.4.539 · Cited by 460 · see citing works
Akbarian, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820150016002 · Cited by 456 · see citing works
Guiding Neuronal Cell Migrations
Marin, O., Valiente, M., Ge, X., & Tsai, L.-H. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001834 · Cited by 417 · see citing works
A disinhibitory microcircuit initiates critical-period plasticity in the visual cortex
Kuhlman, S. J., Olivas, N. D., Tring, E., Ikrar, T., Xu, X., & Trachtenberg, J. T. (2013) · Nature · doi:10.1038/nature12485 · Cited by 412 · see citing works
Sensi, S. L., Yin, H. Z., Carriedo, S. G., Rao, S. S., & Weiss, J. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2414 · Cited by 408 · see citing works
Role of the calcium-binding protein parvalbumin in short-term synaptic plasticity
Caillard, O., Moreno, H., Schwaller, B., Llano, I., Celio, M. R., & Marty, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.230362997 · Cited by 406 · see citing works
Akbarian, S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050061010 · Cited by 398 · see citing works
Galarreta, M., & Hestrin, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192159599 · Cited by 387 · see citing works
Age-related changes in the default mode network are more advanced in Alzheimer disease
Jones, D. T., Machulda, M. M., Vemuri, P., McDade, E. M., Zeng, G., Senjem, M. L., Gunter, J. L., Przybelski, S. A., Avula, R. T., Knopman, D. S., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318233b33d · Cited by 370 · see citing works
Steullet, P., Cabungcal, J.-H., Coyle, J., Didriksen, M., Gill, K., Grace, A. A., Hensch, T. K., LaMantia, A.-S., Lindemann, L., Maynard, T. M., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.47 · Cited by 360 · cited 2× · see citing works
“In rodent models that recapitulate aspects of brain disorders, higher oxidative stress consistently correlates with decreased PV-positive cortical interneurons [92, 93].”
BackgroundSloviter, R. S., Sollas, A. L., Barbaro, N. M., & Laxer, K. D. (1991) · Journal of Comparative Neurology · doi:10.1002/cne.903080306 · Cited by 349 · see citing works
Mitochondria: The calcium connection
Contreras, L., Drago, I., Zampese, E., & Pozzan, T. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.05.005 · Cited by 349 · see citing works
Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment
Konradi, C., & Heckers, S. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00328-5 · Cited by 336 · see citing works
Self-citationKinney, J. W., Davis, C. N., Tabarean, I., Conti, B., Bartfai, T., & Behrens, M. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4722-05.2006 · Cited by 329 · see citing works
Selimbeyoglu, A., Kim, C. K., Inoue, M., Lee, S. Y., Hong, A. S. O., Kauvar, I., Ramakrishnan, C., Fenno, L. E., Davidson, T. J., Wright, M., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah6733 · Cited by 326 · see citing works
Heckers, S., Stone, D., Walsh, J., Shick, J., Koul, P., & Benes, F. M. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.521 · Cited by 322 · see citing works
Resting Brain Connectivity: Changes during the Progress of Alzheimer Disease
Zhang, H.-Y., Wang, S.-J., Liu, B., Ma, Z.-L., Yang, M., Zhang, Z.-J., & Teng, G.-J. (2010) · Radiology · doi:10.1148/radiol.10091701 · Cited by 320 · see citing works
Dikalov, S., Nazarewicz, R. R., Bikineyeva, A. T., Hilenski, L. L., Lassegue, B. P., Griendling, K. K., Harrison, D. G., & Dikalova, A. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4918 · Cited by 312 · see citing works
Kann, O., Papageorgiou, I. E., & Draguhn, A. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.104 · Cited by 295 · see citing works
A Blueprint for the Spatiotemporal Origins of Mouse Hippocampal Interneuron Diversity
Tricoire, L., Pelkey, K. A., Erkkila, B. E., Jeffries, B. W., Yuan, X., & McBain, C. J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0323-11.2011 · Cited by 292 · see citing works
Hippocampal interneurons are abnormal in schizophrenia
Konradi, C., Yang, C. K., Zimmerman, E. I., Lohmann, K. M., Gresch, P., Pantazopoulos, H., Berretta, S., & Heckers, S. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.007 · Cited by 288 · see citing works
Self-citationGABAergic mechanisms of hippocampal hyperactivity in schizophrenia
Heckers, S., & Konradi, C. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.09.041 · Cited by 277 · see citing works
Self-citationJiang, D., Sullivan, P. G., Sensi, S. L., Steward, O., & Weiss, J. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108834200 · Cited by 265 · see citing works
Wöhr, M., Orduz, D., Gregory, P., Moreno, H., Khan, U., Vörckel, K. J., Wolfer, D. P., Welzl, H., Gall, D., Schiffmann, S. N., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.19 · Cited by 258 · see citing works
Calcium-permeable AMPA channels in neurodegenerative disease and ischemia
Kwak, S., & Weiss, J. H. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.05.004 · Cited by 256 · see citing works
Kim, Y.-M., Kim, S.-J., Tatsunami, R., Yamamura, H., Fukai, T., & Ushio-Fukai, M. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00346.2016 · Cited by 251 · see citing works
Schizophrenia-Related Neural and Behavioral Phenotypes in Transgenic Mice Expressing TruncatedDisc1
Shen, S., Lang, B., Nakamoto, C., Zhang, F., Pu, J., Kuan, S. L., Chatzi, C. A., He, S., Mackie, I., Brandon, N. J., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3299-08.2008 · Cited by 250 · see citing works
Interleukin-6 Mediates the Increase in NADPH-Oxidase in the Ketamine Model of Schizophrenia
Behrens, M. M., Ali, S. S., & Dugan, L. L. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4457-08.2008 · Cited by 241 · see citing works
Self-citationFilice, F., Vörckel, K. J., Sungur, A. Ö., Wöhr, M., & Schwaller, B. (2016) · Molecular Brain · doi:10.1186/s13041-016-0192-8 · Cited by 240 · see citing works
Enwright, J. F., Sanapala, S., Foglio, A., Berry, R., Fish, K. N., & Lewis, D. A. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.24 · Cited by 223 · see citing works
Steullet, P., Cabungcal, J.-H., Kulak, A., Kraftsik, R., Chen, Y., Dalton, T. P., Cuenod, M., & Do, K. Q. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3857-09.2010 · Cited by 202 · see citing works
Bidirectional plasticity in fast-spiking GABA circuits by visual experience
Yazaki-Sugiyama, Y., Kang, S., Câteau, H., Fukai, T., & Hensch, T. K. (2009) · Nature · doi:10.1038/nature08485 · Cited by 200 · see citing works
Sahara, S., Yanagawa, Y., O'Leary, D. D. M., & Stevens, C. F. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6412-11.2012 · Cited by 198 · see citing works
Kisvárday, Z. F., Beaulieu, C., & Eysel, U. T. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903270307 · Cited by 195 · see citing works
Harrington, A. J., Raissi, A., Rajkovich, K., Berto, S., Kumar, J., Molinaro, G., Raduazzo, J., Guo, Y., Loerwald, K., Konopka, G., et al. (2016) · eLife · doi:10.7554/elife.20059 · Cited by 193 · see citing works
Kann, O., Huchzermeyer, C., Kovács, R., Wirtz, S., & Schuelke, M. (2011) · Brain · doi:10.1093/brain/awq333 · Cited by 189 · see citing works
Cortical interneuron development: a tale of time and space
Hu, J. S., Vogt, D., Sandberg, M., & Rubenstein, J. L. (2017) · Development · doi:10.1242/dev.132852 · Cited by 189 · see citing works
Piskorowski, R. A., Nasrallah, K., Diamantopoulou, A., Mukai, J., Hassan, S. I., Siegelbaum, S. A., Gogos, J. A., & Chevaleyre, V. (2016) · Neuron · doi:10.1016/j.neuron.2015.11.036 · Cited by 180 · see citing works
Altered Cortical Ensembles in Mouse Models of Schizophrenia
Hamm, J. P., Peterka, D. S., Gogos, J. A., & Yuste, R. (2017) · Neuron · doi:10.1016/j.neuron.2017.03.019 · Cited by 175 · see citing works
Hackos, D. H., Lupardus, P. J., Grand, T., Chen, Y., Wang, T.-M., Reynen, P. H., Gustafson, A. E., Wallweber, H. J. A., Volgraf, M., Sellers, B. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.016 · Cited by 174 · see citing works
Long-Lasting Rescue of Network and Cognitive Dysfunction in a Genetic Schizophrenia Model
Mukherjee, A., Carvalho, F., Eliez, S., & Caroni, P. (2019) · Cell · doi:10.1016/j.cell.2019.07.023 · Cited by 169 · see citing works
Dugan, L. L., Ali, S. S., Shekhtman, G., Roberts, A. J., Lucero, J., Quick, K. L., & Behrens, M. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005518 · Cited by 165 · see citing works
Self-citationDownregulation of Parvalbumin at Cortical GABA Synapses Reduces Network Gamma Oscillatory Activity
Volman, V., Behrens, M. M., & Sejnowski, T. J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3041-11.2011 · Cited by 164 · see citing works
Powell, S. B., Sejnowski, T. J., & Behrens, M. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.049 · Cited by 164 · see citing works
Kim, Y.-H., & Koh, J.-Y. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7990 · Cited by 163 · see citing works
Huntley, G., Vickers, J., Janssen, W., Brose, N., Heinemann, S., & Morrison, J. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-06-03603.1994 · Cited by 161 · see citing works
Kocsis, B. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.002 · Cited by 159 · see citing works
Deficits in Transcriptional Regulators of Cortical Parvalbumin Neurons in Schizophrenia
Volk, D. W., Matsubara, T., Li, S., Sengupta, E. J., Георгиев, Д., Minabe, Y., Sampson, A. R., Hashimoto, T., & Lewis, D. A. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12030305 · Cited by 155 · see citing works
Chung, D. W., Fish, K. N., & Lewis, D. A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16010025 · Cited by 148 · cited 2× · see citing works
“Furthermore, individuals with schizophrenia have a lower density of excitatory synapses on PV-INs [12] and exhibit alterations in gamma oscillations during a working memory task [13].”
BackgroundAutistic Symptoms in Schizophrenia Spectrum Disorders: A Systematic Review and Meta-Analysis
De Crescenzo, F., Postorino, V., Siracusano, M., Riccioni, A., Armando, M., Curatolo, P., & Mazzone, L. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00078 · Cited by 143 · see citing works
Yin, H. Z., Sensi, S. L., Ogoshi, F., & Weiss, J. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-04-01273.2002 · Cited by 143 · see citing works
Populations of hippocampal inhibitory neurons express different levels of cytochrome <i>c</i>
Gulyás, A. I., Buzsáki, G., Freund, T. F., & Hirase, H. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04814.x · Cited by 142 · see citing works
Bitanihirwe, B., Lim, M., Kelley, J., Kaneko, T., & Woo, T. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-71 · Cited by 137 · see citing works
Goldberg, J. H., Yuste, R., & Tamas, G. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.042598 · Cited by 136 · see citing works
Wang, A. Y., Lohmann, K. M., Yang, C. K., Zimmerman, E. I., Pantazopoulos, H., Herring, N., Berretta, S., Heckers, S., & Konradi, C. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0881-4 · Cited by 135 · see citing works
Self-citationCueva Vargas, J. L., Osswald, I. K., Unsain, N., Aurousseau, M. R., Barker, P. A., Bowie, D., & Di Polo, A. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1273-15.2015 · Cited by 132 · see citing works
Barr, M. S., Farzan, F., Tran, L. C., Chen, R., Fitzgerald, P. B., & Daskalakis, Z. J. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.023 · Cited by 125 · see citing works
Cortical interneuron specification: the juncture of genes, time and geometry
Bandler, R. C., Mayer, C., & Fishell, G. (2017) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2016.10.003 · Cited by 125 · see citing works
Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer’s disease
Takahashi, H., Brasnjevic, I., Rutten, B. P. F., Van Der Kolk, N., Perl, D. P., Bouras, C., Steinbusch, H. W. M., Schmitz, C., Hof, P. R., & Dickstein, D. L. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0242-4 · Cited by 124 · see citing works
Jia, Y., Jeng, J., Sensi, S. L., & Weiss, J. H. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.020172 · Cited by 118 · see citing works
Inan, M., Zhao, M., Manuszak, M., Karakaya, C., Rajadhyaksha, A. M., Pickel, V. M., Schwartz, T. H., Goldstein, P. A., & Manfredi, G. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.04.004 · Cited by 118 · see citing works
Laminar fate of cortical GABAergic interneurons is dependent on both birthdate and phenotype
Rymar, V. V., & Sadikot, A. F. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21250 · Cited by 116 · see citing works
Hippocampal Interneurons in Bipolar Disorder
Konradi, C., Zimmerman, E. I., Yang, C. K., Lohmann, K. M., Gresch, P., Pantazopoulos, H., Berretta, S., & Heckers, S. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.175 · Cited by 115 · see citing works
Self-citationLoss of perineuronal net N-acetylgalactosamine in Alzheimer’s disease
Baig, S., Wilcock, G. K., & Love, S. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1060-2 · Cited by 112 · see citing works
Spaethling, J. M., Klein, D. M., Singh, P., & Meaney, D. F. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2008.0532 · Cited by 112 · see citing works
Nissen, W., Szabo, A., Somogyi, J., Somogyi, P., & Lamsa, K. P. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3481-09.2010 · Cited by 105 · see citing works
Volgraf, M., Sellers, B. D., Jiang, Y., Wu, G., Ly, C. Q., Villemure, E., Pastor, R. M., Yuen, P., Lu, A., Luo, X., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b02010 · Cited by 105 · see citing works
Decision making during interneuron migration in the developing cerebral cortex
Guo, J., & Anton, E. S. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.12.001 · Cited by 104 · see citing works
Joseph, L. C., Barca, E., Subramanyam, P., Komrowski, M., Pajvani, U., Colecraft, H. M., Hirano, M., & Morrow, J. P. (2016) · PLOS ONE · doi:10.1371/journal.pone.0145750 · Cited by 99 · see citing works
Ahnaou, A., Moechars, D., Raeymaekers, L., Biermans, R., Manyakov, N. V., Bottelbergs, A., Wintmolders, C., Van Kolen, K., Van De Casteele, T., Kemp, J. A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13839-6 · Cited by 98 · see citing works
Rubio, S. E., Vega‐Flores, G., Martínez, A., Bosch, C., Pérez‐Mediavilla, A., Río, J. D., Gruart, A., Delgado‐García, J. M., Soriano, E., & Pascual, M. (2012) · The FASEB Journal · doi:10.1096/fj.12-208413 · Cited by 98 · see citing works
MS, M. G., HAINFELLNER, J. A., TRABATTONI, G. R., & BUDKA, H. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00005 · Cited by 97 · see citing works
Cabungcal, J.-H., Nicolas, D., Kraftsik, R., Cuénod, M., Do, K. Q., & Hornung, J.-P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.003 · Cited by 96 · see citing works
Dysregulated ErbB4 Splicing in Schizophrenia: Selective Effects on Parvalbumin Expression
Chung, D. W., Volk, D. W., Arion, D., Zhang, Y., Sampson, A. R., & Lewis, D. A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15020150 · Cited by 86 · see citing works
Dysregulation of Parvalbumin Expression in the Cntnap2−/− Mouse Model of Autism Spectrum Disorder
Lauber, E., Filice, F., & Schwaller, B. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00262 · Cited by 86 · see citing works
Huchzermeyer, C., Berndt, N., Holzhütter, H.-G., & Kann, O. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.165 · Cited by 81 · see citing works
McQuail, J. A., Beas, B. S., Kelly, K. B., Simpson, K. L., Frazier, C. J., Setlow, B., & Bizon, J. L. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2332-16.2016 · Cited by 80 · see citing works
Interneurons, tau and amyloid-β in the piriform cortex in Alzheimer’s disease
Saiz-Sanchez, D., De la Rosa-Prieto, C., Ubeda-Banon, I., & Martinez-Marcos, A. (2015) · Brain Structure and Function · doi:10.1007/s00429-014-0771-3 · Cited by 79 · see citing works
Kaplan, E. S., Cooke, S. F., Komorowski, R. W., Chubykin, A. A., Thomazeau, A., Khibnik, L. A., Gavornik, J. P., & Bear, M. F. (2016) · eLife · doi:10.7554/elife.11450 · Cited by 77 · see citing works
Basal forebrain contributes to default mode network regulation
Nair, J., Klaassen, A.-L., Arato, J., Vyssotski, A. L., Harvey, M., & Rainer, G. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712431115 · Cited by 77 · see citing works
Cha, J., Jo, H. J., Kim, H. J., Seo, S. W., Kim, H., Yoon, U., Park, H., Na, D. L., & Lee, J. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12177 · Cited by 76 · see citing works
Timofeeva, O. A., & Levin, E. D. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.038 · Cited by 74 · see citing works
Whittaker, R. G., Turnbull, D. M., Whittington, M. A., & Cunningham, M. O. (2011) · Brain · doi:10.1093/brain/awr018 · Cited by 74 · see citing works
Szabo, A., Somogyi, J., Cauli, B., Lambolez, B., Somogyi, P., & Lamsa, K. P. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0206-12.2012 · Cited by 71 · see citing works
Albuquerque, M. S., Mahar, I., Davoli, M. A., Chabot, J.-G., Mechawar, N., Quirion, R., & Krantic, S. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00030 · Cited by 71 · see citing works
Parvalbumin gene transfer corrects diastolic dysfunction in diseased cardiac myocytes
Wahr, P. A., Michele, D. E., & Metzger, J. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11982 · Cited by 66 · see citing works
Nakamura, T., Matsumoto, J., Takamura, Y., Ishii, Y., Sasahara, M., Ono, T., & Nishijo, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119258 · Cited by 63 · see citing works
Mahar, I., Albuquerque, M. S., Mondragon-Rodriguez, S., Cavanagh, C., Davoli, M. A., Chabot, J.-G., Williams, S., Mechawar, N., Quirion, R., & Krantic, S. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00327 · Cited by 63 · see citing works
Gill, K. M., & Grace, A. A. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571400056x · Cited by 60 · see citing works
Mao, W., Watanabe, T., Cho, S., Frost, J. L., Truong, T., Zhao, X., & Futai, K. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12877 · Cited by 59 · see citing works
Nguyen, P. T., Nakamura, T., Hori, E., Urakawa, S., Uwano, T., Zhao, J., Li, R., Bac, N. D., Hamashima, T., Ishii, Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018004 · Cited by 56 · see citing works
Transgenic labeling of parvalbumin-expressing neurons with tdTomato
Kaiser, T., Ting, J. T., Monteiro, P., & Feng, G. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.036 · Cited by 54 · see citing works
Peyre, E., Silva, C. G., & Nguyen, L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00129 · Cited by 51 · see citing works
Koh, M. T., Shao, Y., Sherwood, A., & Smith, D. R. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.023 · Cited by 51 · see citing works
Abnormal interneuron development in disrupted-in-schizophrenia-1 L100P mutant mice
Lee, F. H., Zai, C. C., Cordes, S. P., Roder, J. C., & Wong, A. H. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-20 · Cited by 49 · see citing works
The developmental changes of Nav1.1 and Nav1.2 expression in the human hippocampus and temporal lobe
Wang, W., Takashima, S., Segawa, Y., Itoh, M., Shi, X., Hwang, S.-K., Nabeshima, K., Takeshita, M., & Hirose, S. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.083 · Cited by 47 · see citing works
Garbelli, R., Meroni, A., Magnaghi, G., Beolchi, M. S., Ferrario, A., Tassi, L., Bramerio, M., & Spreafico, R. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00577.x · Cited by 47 · see citing works
Huntley, G. W., Vickers, J. C., & Morrison, J. H. (1997) · Brain Research · doi:10.1016/s0006-8993(96)00847-5 · Cited by 47 · see citing works
Du, Y., & Grace, A. A. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw065 · Cited by 43 · see citing works
Parvalbumin Promoter Hypermethylation in Postmortem Brain in Schizophrenia
Fachim, H. A., Srisawat, U., Dalton, C. F., & Reynolds, G. P. (2018) · Epigenomics · doi:10.2217/epi-2017-0159 · Cited by 41 · see citing works
Verdaguer, E., Brox, S., Petrov, D., Olloquequi, J., Romero, R., de Lemos, M. L., Camins, A., & Auladell, C. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.06.013 · Cited by 38 · see citing works
Input-specific maturation of synaptic dynamics of parvalbumin interneurons in primary visual cortex
Lu, J., Tucciarone, J., Lin, Y., & Huang, Z. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400694111 · Cited by 35 · see citing works
Wang, L., Shen, M., Jiang, C., Ma, L., & Wang, F. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw060 · Cited by 29 · see citing works
Delevich, K. M., Jaaro-Peled, H., Penzo, M. A., Sawa, A., & Li, B. (2020) · eNeuro · doi:10.1523/eneuro.0496-19.2020 · Cited by 24 · see citing works
Jones, N. C., Hudson, M., Foreman, J., Rind, G., Hill, R., Manning, E. E., & van den Buuse, M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13722 · Cited by 20 · see citing works
Jaaro-Peled, H., Kumar, S., Hughes, D. N., Sumitomo, A., Kim, S.-H., Zoubovsky, S. P., Hirota-Tsuyada, Y., Zala, D., Bruyère, J., Katz, B. M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01389-3 · Cited by 16 · see citing works
Jaaro-Peled, H., Kumar, S., Hughes, D. N., Kim, S.-H., Zoubovsky, S. P., Hirota-Tsuyada, Y., Zala, D., Sumitomo, A., Bruyère, J., Katz, B. M., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/497446 · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
McCutcheon, R. A., Keefe, R. S. E., & McGuire, P. K. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01949-9 · Cited by 800 · see citing works
“For example, because parvalbumin interneurons have extremely high energy requirements, oxidative and metabolic stressors can have a disproportionate impact on these neurons, and their effects may be greatest in regions where they are present at high densities [265].”
BackgroundCortical interneurons in autism
Contractor, A., Ethell, I. M., & Portera‐Cailliau, C. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00967-6 · Cited by 180 · see citing works
Gómez de San José, N., Massa, F., Halbgebauer, S., Oeckl, P., Steinacker, P., & Otto, M. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-021-02411-2 · Cited by 112 · see citing works
Brown, D. A., Altermatt, M., Dobreva, T., Chen, S., Wang, A. Z., Thomson, M. W., & Gradinaru, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.730825 · Cited by 58 · see citing works
Canetta, S. E., Holt, E. S., Benoit, L. J., Teboul, E., Sahyoun, G. M., Ogden, R. T., Harris, A. Z., & Kellendonk, C. (2022) · eLife · doi:10.7554/elife.80324 · Cited by 59 · see citing works
“The importance of this cell population for cortical development is underscored by the fact that they show histological abnormalities in multiple neurological and psychiatric disorders with a presumed neurodevelopmental origin, most classically schizophrenia (Lewis, 2014, Ruden et al., 2021).”
BackgroundSpoleti, E., Barbera, L. L., Cauzzi, E., Paolis, M. L. D., Saba, L., Marino, R., Sciamanna, G., Lazzaro, V. D., Keller, F., Nobili, A., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02408-9 · Cited by 61 · see citing works
Integrated platform for multiscale molecular imaging and phenotyping of the human brain
Park, J., Wang, J., Guan, W., Gjesteby, L., Pollack, D., Kamentsky, L. D., Evans, N. B., Stirman, J., Gu, X., Zhao, C., et al. (2024) · Science · doi:10.1126/science.adh9979 · Cited by 67 · see citing works
“CR+ (in layers I to III), PV+ (in layers III to V), and CR+/PV+ (in layers I to III) interneurons displayed lower density in AD, a pattern potentially associated with neurodegeneration, impaired homeostasis, and calcium-based signaling, consistent with the literature ( 47 , 48 ).”
Tabassum, S., Misrani, A. A., Huang, H., Zhang, Z.-Y., Li, Q.-W., & Long, C. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03395-8 · Cited by 55 · see citing works
Kumar, P., Goettemoeller, A. M., Espinosa‐García, C., Tobin, B. R., Tfaily, A., Nelson, R. S., Natu, A., Dammer, E. B., Santiago, J. V., Malepati, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47028-7 · Cited by 48 · see citing works
“Among neuronal subtypes, PV-INs represent a unique class of inhibitory interneurons with fast-fi ring properties and high metabolic activity 13,98 .”
The fate of interneurons, GABA A receptor sub‐types and perineuronal nets in Alzheimer's disease
Ali, A. B., Islam, A., & Constanti, A. (2022) · Brain Pathology · doi:10.1111/bpa.13129 · Cited by 47 · see citing works
“PV-expressing interneurons are known to be highly vulnerable to stressors [128].”
BackgroundKang, Y., Clement, E. M., Park, I., Greenfield, L. J., Smith, B. N., & Lee, S.-H. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113724 · Cited by 31 · see citing works
Jeong, N., & Singer, A. C. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102604 · Cited by 40 · see citing works
The 40-Hz auditory steady-state response in bipolar disorder: A meta-analysis
Jefsen, O. H., Юрьевич, Ш. Ю., Larsen, K. M., & Dietz, M. J. (2022) · Clinical Neurophysiology · doi:10.1016/j.clinph.2022.06.014 · Cited by 42 · see citing works
“These NMDA-receptor and interneuron dysfunctions are, however, not specific to schizophrenia, but have also been reported in patients with bipolar disorder (Beneyto and Meador-Woodruff, 2008, Clinton and Meador-Woodruff, 2004, Ruden et al., 2021, Scarr et al., 2003, Toker et al., 2018).”
Parvalbumin - Positive Neurons in the Neocortex: A Review
Druga, R., Salaj, M., & Al‐Redouan, A. (2023) · Physiological Research · doi:10.33549/physiolres.935005 · Cited by 42 · see citing works
“Tremendous number of new data and concepts were collected in recent years describing the phenotypic characteristics of PV+ GABAergic interneurons and their operations in cortical microcircuits and larger neocortical assemblies acting as substrate in neurodegenerative processes [23].”
Santos‐Silva, T., Fabris, D. D. S., de Oliveira, C. L., Guimarães, F. S., & Gomes, F. V. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad123 · Cited by 42 · see citing works
Dannenhoffer, C. A., Gómez‐A, A., Macht, V. A., Jawad, R., Sutherland, E. B., Vetreno, R. P., Crews, F. T., Boettiger, C. A., & Robinson, D. L. (2022) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14810 · Cited by 31 · see citing works
Santos‐Silva, T., Colodete, D. A. E., Lisboa, J. R., Freitas, I. D. S., Lopes, C. F. B., Hadera, V., Lima, T. S. A., Souza, A. J., & Gomes, F. V. (2024) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13994 · Cited by 36 · see citing works
“13 Removing its pro-domain leads to MMP activation, which can occur via the action of other MMPs, serine proteinases, nitric oxide and ROS.”
BackgroundInfluentialKlocke, B., Krone, K., Tornes, J., Moore, C., Ott, H., & Pitychoutis, P. M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1093099 · Cited by 35 · see citing works
“Taken together, these studies suggest that the impaired Ca2+ buffering brought about by the absence of PVALB may result in a compensatory proliferation and subplasmalemmal relocation of mitochondria to maintain the rapid Ca2+ dynamics these neurons rely on (Janickova and Schwaller, 2020; Ruden et al., 2021).”
BackgroundInfluentialOláh, V. J., Goettemoeller, A. M., Rayaprolu, S., Dammer, E. B., Seyfried, N. T., Rangaraju, S., Dimidschstein, J., & Rowan, M. J. (2022) · eLife · doi:10.7554/elife.75316 · Cited by 32 · see citing works
“PV-specific vulnerability could manifest as a result of their high metabolic demand ( Ruden et al., 2021 ) or through abnormal regulation of ion channel subunits necessary for maintaining their fast-spiking nature ( Martinez-Losa et al., 2018 ).”
Wu, X., Ji, M., Yin, X., Gu, H., Zhu, T., Wang, R.-Z., Yang, J., & Shen, J.-C. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108724 · Cited by 32 · see citing works
Bucher, E., Collins, J. M., King, A. E., Vickers, J. C., & Kirkcaldie, M. (2021) · Brain Structure and Function · doi:10.1007/s00429-021-02327-3 · Cited by 29 · see citing works
The Engram’s Dark Horse: How Interneurons Regulate State-Dependent Memory Processing and Plasticity
Raven, F., & Aton, S. J. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.750541 · Cited by 27 · see citing works
Development, Diversity, and Death of MGE-Derived Cortical Interneurons
Williams, R. H., & Riedemann, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179297 · Cited by 24 · see citing works
The neural hierarchy of consciousness: A theoretical model and review on neurophysiology and NCCs
Almeida, V. N. (2022) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2022.108202 · Cited by 28 · see citing works
Pinna, A., & Colasanti, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.689473 · Cited by 26 · see citing works
Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction
Aguilar, D. D., Radzik, L. K., Schiffino, F. L., Folorunso, O. O., Zielinski, M. R., Coyle, J. T., Balu, D. T., & McNally, J. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-88428-9 · Cited by 27 · see citing works
Bíró, L., Miskolczi, C., Szebik, H., Bruzsik, B., Varga, Z. K., Szente, L., Tóth, M., Halász, J., & Mikics, É. (2023) · Neurobiology of Stress · doi:10.1016/j.ynstr.2023.100546 · Cited by 26 · see citing works
“Disturbances in glutamatergic drive of PV+ INs and the associated abnormal gamma oscillations have been implicated in various neuropsychiatric disorders, including schizophrenia (Ruden et al., 2021).”
Region-Specific Alterations of Perineuronal Net Expression in Postmortem Autism Brain Tissue
Brandenburg, C., & Blatt, G. J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.838918 · Cited by 25 · see citing works
Tan, Z., Garduño, B. M., Fernández‐Aburto, P., Chen, L., Ha, N. M.-L., Cogram, P., Holmes, T. C., & Xu, X. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01481-x · Cited by 24 · see citing works
“Neurodegeneration is one of the main neuropathological features in the human AD brain and accounts for the significant brain atrophy seen in these patients [33, 34].”
BackgroundMarichal, N., Péron, S., Beltrán-Arranz, A., Galante, C., Scarante, F. F., Wiffen, R., Schuurmans, C. J., Karow, M., Gascón, S., & Berninger, B. (2024) · Science Advances · doi:10.1126/sciadv.adl5935 · Cited by 24 · see citing works
The Role of Perineuronal Nets in Physiology and Disease: Insights from Recent Studies
Auer, S., Schicht, M., Hoffmann, L., Budday, S., Frischknecht, R., Blümcke, I., & Paulsen, F. P. (2025) · Cells · doi:10.3390/cells14050321 · Cited by 30 · see citing works
“…an interneuron dysfunction was shown to be implicated in a variety of psychiatric disorders, including schizophrenia (SZ), autism spectrum disorder (ASD), and bipolar disorder (BPD), and in neurodegenerative disorders, like Alzheimer’s disease (AD), and aging (for a detailed review, see [99]).”
Armenta-Reséndiz, M., Assali, A., Tsvetkov, E., Cowan, C. W., & Lavı́n, A. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01371-9 · Cited by 23 · see citing works
Dufour, B. D., McBride, E., Bartley, T., Juárez, P., & Martínez‐Cerdeño, V. (2023) · Autism · doi:10.1177/13623613231154053 · Cited by 22 · see citing works
NADPH-oxidases as potential pharmacological targets for thrombosis and depression comorbidity
Amadio, P., Sandrini, L., Zarà, M., Barbieri, S. S., & Ieraci, A. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103060 · Cited by 24 · see citing works
“Dysfunction of parvalbumin-positive GABAergic interneurons were correlated with various psychiatric disorders such as depression, schizophrenia, post-traumatic stress disorder and Alzheimer ’ s disease [229].”
BackgroundZahedi, E., Sadr, S. S., Sanaeierad, A., & Roghani, M. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01227-1 · Cited by 21 · see citing works
Kim, E.-G., Chang, W., Shin, S., Adhikari, A. S., Seol, G. H., Song, D., & Min, S. S. (2022) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2023.27.1.113 · Cited by 21 · see citing works
“The long-lasting changes in brain interneuron populations have been proposed to contribute to the pathophysiology of many important neuro-psychiatric disorders [73] since it causes E-I imbalance.”
Ghirardini, E., Sagona, G., Márquez-Galera, Á., Calugi, F., Navarrón, C. M., Cacciante, F., Chen, S., Vetta, F. D., Dadà, L., Mazziotti, R. M., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01533-w · Cited by 20 · see citing works
Li, X., Sun, H., Zhu, Y., Wang, F., Wang, X., Han, L., Cui, D., Luo, D., Zhai, Y., Zhuo, L., et al. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1010152 · Cited by 20 · see citing works
Parvalbumin interneuron-derived tissue-type plasminogen activator shapes perineuronal net structure
Lépine, M., Douceau, S., Devienne, G. F., Prunotto, P., Lenoir, S., Regnauld, C., Pouettre, E., Piquet, J., Lebouvier, L., Hommet, Y., et al. (2022) · BMC Biology · doi:10.1186/s12915-022-01419-8 · Cited by 19 · see citing works
“These FS-PV interneurons are fundamental for several behavioral responses and their dysfunction participates in several diseases, including schizophrenia and autism [35, 73].”
BackgroundZhang, B., Chen, K., Dai, Y., Luo, X., Xiong, Z., Zhang, W., Huang, X., So, K., & Zhang, L. (2024) · Communications Biology · doi:10.1038/s42003-024-06896-x · Cited by 17 · see citing works
“…degenerationincorticalregions 32 ,afewmodelshavebeendiscussedtoexplain the vulnerability of GABAergic neurons under proteinopathy, including the relatively higher energy requirement 33 , or the preference of microglial phagocytosis targeting the extracellular matrix of PV-INs 34 .”
BackgroundImaging high-frequency voltage dynamics in multiple neuron classes of behaving mammals
Haziza, S., Chrapkiewicz, R., Zhang, Y., Kruzhilin, V., Li, J., Li, J., Delamare, G., Swanson, R. A., Buzsáki, G., Kannan, M., et al. (2025) · Cell · doi:10.1016/j.cell.2025.06.028 · Cited by 18 · see citing works
Maternal P7C3-A20 Treatment Protects Offspring from Neuropsychiatric Sequelae of Prenatal Stress
Schroeder, R. E., Sridharan, P. S., Nguyen, L. T., Loren, A., Williams, N. S., Kettimuthu, K. P., Cintrón-Pérez, C. J., Vázquez‐Rosa, E., Pieper, A. A., & Stevens, H. E. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8227 · Cited by 17 · see citing works
Wei, J., Liu, L., Song, X., Lin, B., Cui, J., Luo, L., Liu, Y., Li, S., Li, X., So, K., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112240 · Cited by 17 · see citing works
Parvalbumin as a sex-specific target in Alzheimer’s disease research – A mini-review
Terstege, D. J., & Epp, J. R. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105370 · Cited by 14 · see citing works
“However, it appears that markers of altered metabolism, sex hormones, and inflammation each seem better suited as predictors of PV neuron loss (Cabungcal et al., 2006; Filice et al., 2018; Ruden et al., 2021; Steullet et al., 2017).”
Colodete, D. A. E., Grace, A. A., Guimarães, F. S., & Gomes, F. V. (2024) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2024.100338 · Cited by 16 · see citing works
“This imbalance can generate reactive oxygen species, mitochondrial membrane rupture, and subsequent activation of apoptotic pathways (13,47).”
Schreiber, C. S., Ramil, L. N., Bieligk, J., Meineke, R., Rimmelzwaan, G. F., Käufer, C., & Richter, F. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.05.021 · Cited by 14 · see citing works
Krajčíková, K., Semančíková, E., Zakuťanská, K., Kondrakhova, D., Mašlanková, J., Stupák, M., Talian, I., Tomašovičová, N., Kimáková, T., Komanický, V., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.03.038 · Cited by 15 · see citing works
Santos‐Silva, T., Lopes, C. F. B., Ülgen, D. H., Guimarães, D. A., Guimarães, F. S., Alberici, L. C., Sandi, C., & Gomes, F. V. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae033 · Cited by 19 · see citing works
Yu, H., Shao, M., Luo, X., Pang, C., So, K., Yu, J., & Zhang, L. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.377771 · Cited by 14 · see citing works
“(i) The relatively high energy requirement (Ruden et al., 2021): Under normal physiological conditions, the fast-spiking feature of PV-interneurons confers a high energy demand (Kann et al., 2014), making them the primary target when cellular metabolism is disrupted, as it is by pilocarpine (Lee et…”
BackgroundSantos‐Silva, T., Souza, B. K., Colodete, D. A. E., Campos, L. R., Lima, T. S. A., Guimarães, F. S., & Gomes, F. V. (2024) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae042 · Cited by 16 · see citing works
Loss of KCC2 in GABAergic Neurons Causes Seizures and an Imbalance of Cortical Interneurons
Zavalin, K. A., Hassan, A., Fu, C., Delpire, E. J., & Lagrange, A. H. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.826427 · Cited by 13 · see citing works
Hameed, M. Q., Hodgson, N., Lee, H. H. C., Pascual-Leone, A., MacMullin, P., Jannati, A., Dhamne, S. C., Hensch, T. K., & Rotenberg, A. (2022) · Cerebral Cortex · doi:10.1093/cercor/bhac327 · Cited by 14 · see citing works
The metabolic engine of cognition: microglia–neuron interactions in health, ageing and disease
Asimakidou, E., Pluchino, S., Silva, B. A., & Peruzzotti‐Jametti, L. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01409-4 · Cited by 21 · see citing works
Wang, S. H., Lee, D.-S., Kim, T.-H., Kim, J.-E., & Kang, T. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07050-5 · Cited by 13 · see citing works
“These fi ndings indicate that both CDK5-DRP1-mediated mitochondrial fi ssion and impaired GPx1-mediated NF-κ B inhibition may diminish PV expression, which may lead to PV neuronal degeneration following SE.”
InfluentialKang, J.-B., Park, D.-J., Shah, M.-A., & Koh, P. (2022) · Journal of Veterinary Science · doi:10.4142/jvs.21273 · Cited by 13 · see citing works
“Parvalbumin protects the mitochondria from calcium overload by inhibiting a depolarization-induced calcium increase and buffering calcium in an intracellular environment [15].”
BackgroundIntegrated platform for multi-scale molecular imaging and phenotyping of the human brainPreprint
Park, J., Wang, J., Guan, W., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.13.484171 · Cited by 12 · see citing works
Calcium-binding protein parvalbumin in the spinal cord and dorsal root ganglia
Veshchitskii, A. A., & Merkulyeva, N. S. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105634 · Cited by 12 · see citing works
Morphett, J., Whittaker, A. L., Reichelt, A. C., & Hutchinson, M. R. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105568 · Cited by 12 · see citing works
“PV neurons are fast-spiking GABAergic interneurons which are vulnerable to the environment and are implicated in various neurodevelopmental disorders (Ruden et al., 2021).”
BackgroundAn, D., You, Y., Ma, Q., Xu, Z., Liu, Z., Liao, R., Chen, H., Wang, Y., Wang, Y., Dai, H., et al. (2025) · Neuron · doi:10.1016/j.neuron.2024.12.002 · Cited by 13 · see citing works
Linking Social Cognition, Parvalbumin Interneurons, and Oxytocin in Alzheimer’s Disease: An Update
Černotová, D., Hrůzová, K., Levčík, D., Svoboda, J., & Stuchlı́k, A. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230333 · Cited by 12 · see citing works
“Although the AD pathology was studied primarily in terms of dysfunction of glutamatergic and cholinergic systems, there is growing evidence that GABAergic, i.e., inhibitory signaling is affected in the early stages of this disorder, leaving a negative impact on the E/I balance [27, 55–60].”
BackgroundAllami, P., Yazdanpanah, N., & Rezaei, N. (2025) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0153 · Cited by 11 · see citing works
Possible Role of Parvalbumin Interneurons in Meditation and Psychiatric Illness
Thippaiah, S. M., Pradhan, B., Voyiaziakis, E., Shetty, R., Iyengar, S., Olson, C., & Tang, Y. (2022) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.21050136 · Cited by 11 · see citing works
Huang, T.-H., Lin, Y.-S., Hsiao, C., Wang, L.-Y., Ajibola, M. I., Abdulmajeed, W. I., Lin, Y., Li, Y., Chen, C.-Y., Lien, C., et al. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1146278 · Cited by 11 · see citing works
“Consequently, dysfunction of inhibition is associated with various brain disorders (Belelli et al., 2009; Baroncelli et al., 2011; Ruden et al., 2021; Song et al., 2021; Yang et al., 2022).”
Brown, D. A., Altermatt, M., Dobreva, T., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.25.449955 · Cited by 11 · see citing works
Zhang, X., Wu, M., Cheng, L., Cao, W., Liu, Z., Yang, S., & Kim, M. S. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02756-6 · Cited by 11 · see citing works
“Consequently, the de fi ning phenotype of PV-INs is an FS action potential associated with high-energy consumption [24, 85].”
Fin, N. A. S. H., Yip, A., Scott, J. T., Teo, L., Homman‐Ludiye, J., & Bourne, J. A. (2025) · Development · doi:10.1242/dev.204254 · Cited by 13 · see citing works
Age-related inflammatory changes and perineuronal net dynamics: implications for aging
Colon, Z. A., Chan, S. C., & Maguire‐Zeiss, K. A. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03568-3 · Cited by 10 · see citing works
“Dysfunction of these cells has previously been linked to epilepsy, schizophrenia, and autism [21, 22], as well as PD [23] and AD [24].”
Haikonen, J., Szrinivasan, R., Ojanen, S., Rhee, J. K., Ryazantseva, M., Sulku, J., Zumaraite, G., & Lauri, S. E. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02641-2 · Cited by 10 · see citing works
“The existing research linking PV IN dysfunction to neuropsychiatric conditions, especially schizophrenia is extensive, comprising both of human and animal model studies 46,47,69–72 .”
BackgroundForebrain expression of serine racemase during postnatal development
Folorunso, O. O., Harvey, T. L., Brown, S. E., Cruz, C., Shahbo, E., Ajjawi, I., & Balu, D. T. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104990 · Cited by 12 · see citing works
Fournier, L. A., Phadke, R. A., Salgado, M., Brack, A., Nocon, J. C., Bolshakova, S., Grant, J. R., Padró-Luna, N. M., Sen, K., & Cruz‐Martín, A. (2024) · iScience · doi:10.1016/j.isci.2024.110800 · Cited by 9 · see citing works
Minetti, A., Montagni, E., Meneghetti, N., Macchi, F., Coulomb, É., Martello, A., Tiberi, A., Capsoni, S., Mazzoni, A., Mascaro, A. L. A., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01052-6 · Cited by 10 · see citing works
Gamma Activity in Sensory and Cognitive Processing
Strüber, D., & Herrmann, C. S. (2022) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780192898340.013.8 · Cited by 8 · see citing works
Prepubertal ovariectomy confers resilience to stress-induced anxiety in adult female mice
Woodward, E. M., Ringland, A., Ackerman, J., & Coutellier, L. D. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105997 · Cited by 8 · see citing works
Defects of parvalbumin-positive interneurons are implicated in psychiatric disorders
Zhao, F., & Guan, W. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116599 · Cited by 9 · see citing works
Song, C., Zhao, Y. G., Zhang, J., Dong, Z., Kang, X., Pan, Y., Du, J., Gao, Y., Zhang, H., Ye, X., et al. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01083-0 · Cited by 8 · see citing works
“PV interneurons are vulnerable under pathological conditions [14].”
BackgroundKlimczak, P., Alcaide, J., Gramuntell, Y., Castillo-Gómez, E., Varea, E., Pérez-Rando, M., & Nácher, J. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03166-6 · Cited by 7 · see citing works
“Consequently, it is unsurprising that alterations in their density, connectivity, and physiology have been found in different psychiatric disorders with a neurodevelopmental origin, such as schizophrenia [5, 6].”
Kang, J.-B., Park, D.-J., & Koh, P. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03769-9 · Cited by 7 · see citing works
“It is interconnected with electrical and chemical synapses in the cerebral cortex, regulating sensory response, learning, and synaptic plasticity [17].”
BackgroundDOT1L deletion impairs the development of cortical parvalbumin-expressing interneurons
Cheffer, A., Garcia‐Miralles, M., Maier, E., Akol, I., Franz, H., Srinivasan, V. S. V., & Vogel, T. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad281 · Cited by 7 · see citing works
“Indeed, impairments in GABAergic neurotransmission and consequently altered E-I balance are implicated in many neurological and psychiatric conditions, including Alzheimer’s disease, epilepsy, schizophrenia, autism, depression and mood disorders (reviewed in Nahar et al. 2021; Prévot and Sibille 2021; Ruden et al. 202…”
BackgroundHuang, D., Li, M., Qiao, Z., Zhou, H., Cai, Y., Li, X., Zhang, Z., & Zhou, J. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2024.06.006 · Cited by 7 · see citing works
“Notably, alterations in cognitive function have been closely linked to impaired PV + interneurons (Ruden et al., 2021).”
BackgroundSullivan, E. D. K., Dannenhoffer, C. A., Sutherland, E. B., Vidrascu, E. M., Gómez‐A, A., Boettiger, C. A., & Robinson, D. L. (2024) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15395 · Cited by 6 · see citing works
Ratner, M. H., & Farb, D. H. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.836427 · Cited by 7 · see citing works
“The hippocampus is vulnerable to adverse effects of drugs and neurotoxicants (Tsunashima et al., 1998; Campbell et al., 2004; Bowyer and Ali, 2006; Bowyer et al., 2008; Ruden et al., 2021)”
BackgroundCortical interneuron development is affected in 4H leukodystrophy
Dooves, S., Kok, L. M. L., Holmes, D. B., Breeuwsma, N., Breur, M., Bugiani, M., Wolf, N. I., & Heine, V. M. (2023) · Brain · doi:10.1093/brain/awad017 · Cited by 8 · see citing works
“spiking interneurons with a high metabolic demand, which makes them vulnerable for injury.(64) Interestingly, the development of SST and PV interneurons is depending on SHH levels,(65,66) and deletion of Arx in PV neurons led to increased neuronal activity and altered synaptic properties in a mouse model.”
Dang, T. N., Tien, S. N., Ochi, R., Le, D. T., Nishio, K., Kuwamura, H., Kurose, T., Fujita, N., Nishijo, H., Nakamura, Y., et al. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114786 · Cited by 6 · see citing works
Hippocampal parvalbumin and perineuronal nets: Possible involvement in anxiety‐like behavior in rats
Fan, Z., Gong, X., Xu, H., Qu, Y., Li, B., Li, L., Yan, Y., Wu, L., & Yan, C. (2023) · Hippocampus · doi:10.1002/hipo.23595 · Cited by 7 · see citing works
“autism spectrum disorder, and bipolar disorder (Ruden et al., 2021; Song et al., 2021).”
Emerging Perspectives on Neuroprotection
Hasler, G., & Inta, D. (2024) · Psychotherapy and Psychosomatics · doi:10.1159/000540032 · Cited by 6 · see citing works
“Vulnerability is conferred mainly by their very high energy demand, re-fl ected by unique enrichment with mitochondria and are highly vulnerable to stressors [12].”
Zheng, Y., Wang, W., Xia, S., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.09.012 · Cited by 6 · see citing works
Rethinking parvalbumin: From passive marker to active modulator of hippocampal circuits
Zhang, N., Hu, B., Li, X., & Huang, H. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.10.005 · Cited by 7 · see citing works
“Their high metabolic demands, extensive connectivity, and constant high-frequency activity make them exquisitely sensitive to a wide range of insults (Kann et al., 2014; Ruden et al., 2021; Yao et al., 2020).”
InfluentialOkuzono, S., Fujii, F., Matsushita, Y., Setoyama, D., Shinmyo, Y., Taira, R., Yonemoto, K., Akamine, S., Motomura, Y., Sanefuji, M., et al. (2023) · Neuroscience Research · doi:10.1016/j.neures.2023.03.001 · Cited by 6 · see citing works
Brandt, M. J. V., Kosmeijer, C. M., Achterberg, E. J. M., de Theije, C. G. M., & Nijboer, C. H. A. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100817 · Cited by 7 · see citing works
“…2020; Desfeux et al., 2010; Roux et al., 2015), and hypomyelination (Lim et al., 2018; Hafner et al., 2019; Wamsley and Fishell, 2017), due to their energy requirements, excitatory inputs and developmental trajectory (Zhang et al., 2016; Ruden et al., 2021; Juarez and Martínez-Cerde ˜ no, 2022).”
Long‐range inputome of prefrontal GABAergic interneurons in the Alzheimer's disease mouse
Ren, M., Li, Y., Jiang, T., Liu, B., Li, X., Jia, X., Li, A., Luo, Q., Gong, H., & Li, X. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14552 · Cited by 6 · see citing works
Olfactory deficits in aging and Alzheimer’s—spotlight on inhibitory interneurons
Elhabbari, K., Sireci, S., Rothermel, M., & Brunert, D. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1503069 · Cited by 6 · see citing works
“Significant reductions in the densities of SST and CR interneurons were observed in the LEC of an AD mouse model compared to wild-type (WT) mice (Figure 2A; Klein et al., 2016) while fast-spiking PV-expressing interneurons do not show a significant decline (Ruden et al., 2021).”
Human mutations in SLITRK3 implicated in GABAergic synapse development in mice
Efthymiou, S., Han, W., Ilyas, M., Li, J., Yu, Y., Scala, M., Malintan, N. T., Vavouraki, N., Mankad, K., Maroofian, R., et al. (2022) · bioRxiv · doi:10.3389/fnmol.2024.1222935 · Cited by 4 · see citing works
“Parvalbumin (PV) interneurons in the hippocampus are mostly basket cells with fast-spiking actions at a high energy cost, are highly vulnerable to stressors, and have been implicated in many neuropsychiatric disorders (Ruden et al., 2020).”
BackgroundBanerjee, T., Pati, S., Tiwari, P., & Vaidya, V. A. (2022) · Journal of Biosciences · doi:10.1007/s12038-022-00308-0 · Cited by 6 · see citing works
“In this regard, our approach to chemogenetically manipulate PV-positive interneurons during postnatal development across diverse circuits bears relevance to both models of early adversity and neurodevelopmental disorders, which impact PV-positive interneurons across several limbic brain regions (Ruden et al. 2021).”
BackgroundInfluentialChalatsi, T., Fernandez, L. M. J., Scholler, J., Batti, L., Kolaxi, A., Restivo, L., Lüthi, A., Mameli, M., & Nikoletopoulou, V. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.10.511533 · Cited by 5 · see citing works
Kumar, P., Goettemoeller, A. M., Espinosa‐García, C., Tobin, B. R., Tfaily, A., Nelson, R. S., Natu, A., Dammer, E. B., Santiago, J. V., Malepati, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.17.541038 · Cited by 4 · see citing works
Fin, N. A. S. H., Yip, A., Teo, L., Homman‐Ludiye, J., & Bourne, J. A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.10.602904 · Cited by 3 · see citing works
Bakos, E., Tiszlavicz, Á., Szegedi, V., Douida, A., Furdan, S., Welter, D. K., Landry, J. J. M., Bende, B., Hutóczki, G., Barzó, P., et al. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003549 · Cited by 4 · see citing works
“Slowed inhibitory signaling in the human neocortex would be detrimental, as theoretical models and in vivo animal studies have linked such changes to reduced cortical computation speed and cognitive impairment [40,72–75].”
Manns, M., Juckel, G., & Freund, N. (2025) · Brain Sciences · doi:10.3390/brainsci15020169 · Cited by 5 · see citing works
Zhang, X.-R., Cheng, L., Yang, S.-B., jin, M., Piao, Q.-Y., Kim, D.-W., & Kim, M.-S. (2025) · Current Neuropharmacology · doi:10.2174/011570159x356939250306075324 · Cited by 3 · see citing works
“The energy requirements of PV-INs make them highly susceptible to oxidative stress and the loss of mitochondrial membrane potential in neurodegenerative diseases [24, 29].”
- Authors
- Ruden, J. B., Dugan, L. L., & Konradi, C.
- Affiliations
- Vanderbilt University (US)
- Corresponding author
- Konradi, Christine
- Venue
- Neuropsychopharmacology
- Published
- 2020-07-28
- Volume
- 46
- Issue
- 2
- Pages
- 279-287
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- PMC
- PMC7852528
- OpenAlex
- W3044343625
- Semantic Scholar
- 2c4e5394f3b88323dda4206c07141d738c058a9c
- Cited by
- 194
- References
- 148
- Citations by year
- 2026: 33 · 2025: 50 · 2024: 36 · 2023: 31 · 2022: 28 · 2021: 16
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX004321)
- Vanderbilt University
- Vanderbilt Institute for Clinical and Translational Research
- Geriatric Research Education and Clinical Center
- National Institute on Aging (R01AG058856)
- National Center for Research Resources (KL2RR024977)
- NIH Clinical Center
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural dynamics and brain function
- Keywords
- parvalbumin interneurons, neuronal vulnerability, stressors, schizophrenia, Alzheimer's disease, autism spectrum disorder, bipolar disorder, excitatory drive, energy requirements, interneuron development, neuroprotection
- MeSH terms
- Autism Spectrum Disorder, Alzheimer Disease, Humans, Interneurons, Neurons, Parvalbumins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review